CN111321171A - Method for preparing gene targeting animal model by applying CRISPR/Cas9 mediated ES targeting technology - Google Patents

Method for preparing gene targeting animal model by applying CRISPR/Cas9 mediated ES targeting technology Download PDF

Info

Publication number
CN111321171A
CN111321171A CN201811535721.7A CN201811535721A CN111321171A CN 111321171 A CN111321171 A CN 111321171A CN 201811535721 A CN201811535721 A CN 201811535721A CN 111321171 A CN111321171 A CN 111321171A
Authority
CN
China
Prior art keywords
targeting
dna
cas9
sgrna
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201811535721.7A
Other languages
Chinese (zh)
Inventor
琚存祥
赵静
张明坤
吴丹
侯欢欢
高翔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gempharmatech Co ltd
Original Assignee
Gempharmatech Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gempharmatech Co ltd filed Critical Gempharmatech Co ltd
Priority to CN201811535721.7A priority Critical patent/CN111321171A/en
Publication of CN111321171A publication Critical patent/CN111321171A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • C12N15/902Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027New or modified breeds of vertebrates
    • A01K67/0275Genetically modified vertebrates, e.g. transgenic
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases RNAses, DNAses
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/07Animals genetically altered by homologous recombination
    • A01K2217/072Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/07Animals genetically altered by homologous recombination
    • A01K2217/075Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00Animals characterised by species
    • A01K2227/10Mammal
    • A01K2227/105Murine
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00Animals characterised by purpose
    • A01K2267/03Animal model, e.g. for test or diseases

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Environmental Sciences (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention discloses a method for targeting by applying a CRISPR/Cas9 system gene, which comprises the steps of selecting a mutant of Cas9 with DNA single-strand cutting capacity, using a tracrRNA/crRNA binary complex or an sgRNA aiming at each targeting site, and identifying conserved interval adjacent motifs near the targeting site by the mutant of Cas9 to generate DNA single-strand cuts without generating DNA double-strand breaks and inducing the homologous recombination and repair of the single-strand cuts. The invention also provides a method for preparing a gene targeting animal model by utilizing the method-mediated ES targeting technology. The invention reduces the insertion deletion mutation caused by HMEJ repair in the gene targeting process, and obtains high-efficiency targeting positive clone. The invention can be used as a platform technology to be widely used for preparing gene targeting animal models.

Description

Method for preparing gene targeting animal model by applying CRISPR/Cas9 mediated ES targeting technology
Technical Field
The invention belongs to the technical field of gene editing, and particularly relates to a method for preparing a gene targeting animal model by applying a CRISPR/Cas9 mediated ES targeting technology.
Background of the study
Animal models are indispensable tools for studying human medicine and health, and the physiological and pathological processes of the animal models in life activities have many similarities with human beings and can be used as references for human research. Through different gene editing methods, animal models of gene modification can be obtained, so that the occurrence, treatment and the like of related diseases can be researched.
Gene editing is realized by replacing, cutting off or adding or inserting a foreign DNA sequence into a nucleotide sequence of a target gene in a cell genome to generate heritable changes. Unlike random mutation of DNA caused by ray or chemical mutagen, the gene editing technology is directed to change the composition and structure of gene and has the features of high efficiency, controllability and directional operation. Therefore, the gene editing technology is evaluated as ten-major breakthrough science technology in 2014 by the science and technology review of majors science and technology, wherein CRISPR gains the breakthrough prize of life science in 2015.
After a single-strand break or deletion of a DNA molecule in a cell, it is easily repaired by various repair mechanisms in the cell without any change, but the result of the DNA double-strand break is very different. There are two major modes of repair of DNA double strand breaks in cells, Homologous recombination repair (HDR) and Non-Homologous End-link repair (Non-homologus End Join, NHEJ). After double-strand break of DNA, if there are sequences homologous to both ends of the break in the cell, then homologous recombination repair is carried out, and exogenous DNA segment can be inserted into the broken sequence to knock out the original gene or insert exogenous gene into genome DNA to form so-called gene knock-in; double-stranded broken DNA molecules are joined by NHEJ if no homologous sequence is present in the cell, and such "hard" joining is likely to result in deletion, addition or alteration of bases to cause mutations due to the lack of available template. DNA double strand breaks are a serious injury to the genome, but such changes are needed to study gene function.
The traditional ES cell (embryonic stem cell) targeting is a molecular biology technology based on homologous recombination and embryonic stem cell technology. Although homologous recombination-mediated gene targeting can change the homologous sequence with high accuracy, the recombination efficiency of the target gene is very low, and great challenges are brought to large-scale application of gene targeting experiments.
In recent years, a new idea is provided for optimizing a gene targeting technology for the research and application of a CRISPR/Cas9 technology. CRISPR/Cas9 is an acquired immune defense mechanism that has evolved from bacteria and archaea to cope with constant attacks by viruses and plasmids. In this system, crRNA (CRISPR-derived RNA) binds to tracrRNA (trans-activating RNA) by base pairing to form double-stranded RNA, and this tracrRNA/crRNA binary complex directs Cas9 protein to cleave double-stranded DNA at the targeted site of the crRNA guide sequence. In the process of genome editing, tracrRNA and crRNA can be fused into 1 single guide nucleotide (sg RNA) for expression, and can also play a role in targeted shearing, and cells repair broken double strands, so that accurate genome editing is realized. However, the double-strand break can introduce non-negligible off-target mutation at the relevant site, which brings risks to clinical application. Cas9 is a nuclease Cas9 nicke (Cas9n) that creates a single-strand nick by creating a double-strand break through the two nuclease domains RuvC and HNH, converting one of the two key structures to alanine (D10A or H840A). Cas9n requires a pair of sgrnas to guide to achieve targeted double strand cleavage, reducing off-target effects.
However, when the Cas9 protein-mediated ES targeting technology is used for gene modification, both the WT Cas9 and the Cas9n protein introduce double-strand breaks, which can cause HMEJ repair of the genome, lead to the occurrence of non-target bands during genotype identification, interfere with positive band judgment, and are not favorable for selecting positive clones for injection inheritance.
Furthermore, whether homologous recombination can occur efficiently is influenced by a number of factors, Thomas et al (Thomas KR, Capecchi MR. Site-directed mutagenesis by gene targeting in mouse-derived stem cells. cell,1987,51(3): 503-12) found that the efficiency of homologous recombination can be increased by a factor of 10 when the length of the homologous sequence is increased from 4kb to 9 kb. However, the identification difficulty of the PCR method is increased by overlong homologous sequences, the targeting efficiency and the identification difficulty of the PCR are balanced, and the existing overlong homologous sequences have no good method for solving the problem of the PCR identification.
Disclosure of Invention
Aiming at the defects of the prior art, the invention utilizes the characteristic that the Cas9 mutant generates DNA single-strand break, uses a tracrRNA/crRNA binary complex or a gRNA to generate DNA single-strand nick aiming at each targeting site, does not generate DNA double-strand break, induces single-strand nick homologous recombination repair, and reduces insertion deletion mutation brought by HMEJ repair. Furthermore, the CRISPR/Cas9 gene editing technology is combined with the traditional ES targeting technology, and the ES cells (embryonic stem cells) are used for testing the sgRNA cutting efficiency to screen out the high-efficiency sgRNA. And then Cas9 mutant protein and the screened high-efficiency sgRNA of the targeted recombination site are added in the ES targeting process, so that the targeting efficiency can be obviously improved.
The specific technical scheme of the invention is as follows:
a method for gene targeting by using a CRISPR/Cas9 system is characterized in that a mutant of Cas9 with DNA single-strand cutting capacity is selected based on the CRISPR/Cas9 system, a tracrRNA/crRNA binary complex or an sgRNA is used for each targeting site, and the mutant of Cas9 recognizes conserved spacer adjacent motifs near the targeting site to generate DNA single-strand cuts without generating DNA double-strand breaks and induce the homologous recombination repair of the single-strand cuts.
The types of gene targeting in the method of the invention include gene knockout and gene knock-in.
The mutant of Cas9 in the method of the invention is preferably Cas9n D10A and/or H840A.
Furthermore, the method of the invention can design at least 2 targeting sites aiming at each target gene to improve the targeting efficiency or simultaneously carry out multiple gene targeting, the interval of each targeting site is not less than 100bp, and the adjacent DNA single-strand nicks are ensured to be separated by enough distance without generating double-strand break.
Another object of the present invention is to provide a method for preparing gene targeting ES cells using CRISPR/Cas9 system, comprising the steps of:
(1) selecting a proper targeting site according to the type of gene targeting and a target gene, and designing a homologous DNA donor and an identification scheme;
(2) the method for targeting by using the CRISPR/Cas9 system gene is adopted to prepare a mutant of Cas9 or an expression vector thereof, and an sgRNA or a tracrRNA/crRNA binary complex or respective expression vectors are designed and prepared according to a target gene and a targeting site;
alternatively, a mutant of Cas9, sgRNA, or a co-expression vector of crRNA and tracrRNA is prepared;
(3) transfecting the mutant of Cas9, sgRNA or tracrRNA/crRNA binary complex prepared in the step (1), or respective expression vectors or co-expression vectors into ES cells, and selecting a non-homologous DNA template according to the type of gene targeting to enable a targeting site to have base insertion or deletion, or simultaneously transfecting homologous donor DNA to insert exogenous DNA into a genome;
(4) extracting ES cell DNA to perform PCR identification and/or Southern Blot detection and karyotype identification, and identifying the clone which passes the identification to be the gene targeting positive ES cell.
The invention can directly prepare a mutant of Cas9, sgRNA or a tracrRNA/crRNA binary complex to transfect into ES cells, can also prepare respective expression vectors or co-expression vectors to infect into ES cells, preferably directly prepare the mutant of Cas9, sgRNA or the tracrRNA/crRNA binary complex to transfect into the ES cells, and can avoid the problem of expression efficiency after the expression vectors or the co-expression vectors are infected into the ES cells.
In the above method, preferably, the step (2) further comprises detecting the cleavage efficiency and off-target effect of the sgRNA or the binary complex of crRNA and tracrRNA. The detection comprises an endonuclease detection method, an SSA report carrier detection method, a Sanger sequencing method and a Digenome-Seq technology. Preferably, the method for detecting an endonuclease is an enzyme selected from the group consisting of SURVEYOR enzyme, T7EN1 enzyme.
In a specific embodiment of the invention, a wild Cas9, sgRNA or tracrRNA/crRNA binary complex, or respective expression vectors or co-expression vectors are transfected into an ES cell, a cell genome is extracted, a target cutting region is amplified by using a specific primer, the obtained PCR product is subjected to T7EN1 enzyme cutting, electrophoresis detection is carried out after enzyme cutting, and the detection result shows that one or more bands are added as effective cutting compared with a control group; or performing Sanger sequencing on the obtained PCR product, and comparing sequencing results to show that double peaks in the sgRNA area are regarded as effective cutting; and screening high-efficiency sgRNA or crRNA and tracrRNA.
The method for transfecting the ES cells comprises viral transfection, lipofection and electrotransfection.
The invention also aims to provide a method for preparing a gene targeting animal model by using CRISPR/Cas9 mediated ES targeting technology, which comprises the steps of injecting the gene targeting positive ES cells prepared by using the method for preparing the gene targeting ES cells by using the CRISPR/Cas9 system into animal blastocysts, respectively transplanting the blastocysts into surrogate mothers, feeding, and obtaining offspring which is the F0 generation gene targeting animal model. Preferably, the gene targeting animal model of the present invention is a mammal, preferably a mouse or a rat. Preferably, the gene targeting animal model is a KO, cKO, KI, KO first and TM mouse model.
The method of the invention is suitable for knocking-in or knocking-out all genes. The animal models specifically listed in the invention are PRKAA1-KI, CD27-KI and ANXA8-CKO mouse models.
The invention also aims to provide a method for improving screening efficiency of the target-targeting ES positive clone mediated based on the CRISPR/Cas9 system, a CRISPR/Cas9 system is utilized to select a mutant of Cas9 with DNA single-strand cutting capacity, a tracrRNA/crRNA binary complex or an sgRNA is used for each target-targeting site, and the mutant of Cas9 recognizes conserved spacer adjacent motifs near the target-targeting site to generate DNA single-strand cuts without generating double-strand breaks and induce homologous recombination repair of the single-strand cuts.
The wild-type Cas9 and the mutant Cas9n or expression vectors thereof can be prepared by referring to the prior art (Cong, Le, et al, "Multiplex genome engineering using CRISPR/Cas systems." Science (2013): 1231143.) and can also be prepared by entrusted commercial companies. sgRNA or tracrRNA/crRNA design and preparation sgRNA for engineered sites sgRNA can be designed from targeted genes and targeted sites using the Cas9sgRNA design website, e.g., using the website http:// cruispr. Sgrnas with scores of 60 or more were selected, with higher scores indicating higher sgRNA specificity and smaller corresponding off-target effects.
The sgRNA transcription vector can be constructed by reference to the prior art or prepared by entrusted commercial companies.
The specific operation is as follows:
1) designing an sgRNA primer;
the sgRNA sequence was ordered as a forward primer and the reverse complement of the sgRNA sequence was ordered as a reverse primer.
2) Constructing an sgRNA transcription vector;
the forward and reverse primers were annealed to form a double strand, and ligated to BsaI single-digested pUC57-T7 vector to construct a transcription vector containing the sgRNA sequence.
3) Preparing an in vitro transcription template by PCR amplification;
PCR was performed using PrimerStar Max system, sgRNA-F, sgRNA-R as primers, and pUC57-sgRNA plasmid with correct sequence as template, at 95 ℃ for 5min, 95 ℃ for 30s, 58 ℃ for 30s, 72 ℃ for 40s, 72 ℃ for 5min, 30 cycles. And (4) after the program is finished, carrying out agarose gel electrophoresis, cutting a target band, carrying out gel recovery, and recovering the obtained final product as a transcription template.
4) Transcription in vitro using transcription templates and purification.
Reagent I: HiScribeTMT7 Quick High Yield RNA Synthesis Kit(NEB#E2050S);
And (2) reagent II: ambion Megaclear kit (Ambion AM 1908);
press HiScribeTMThe RNA was transcribed in vitro in the manual of the T7 Quick High Yield RNA Synthesis Kit (NEB # E2050S), and RNA was purified according to the manual of the Ambion megaclean Kit (Ambion AM 1908). the concentration of the recovered RNA was measured by UV spectrophotometry, and 9. mu.l of 1 × Loadingbuffer was added to 1. mu.l of the RNA sample, and agarose gel electrophoresis was performed. The remaining RNA samples were stored at-80 ℃.
The invention has the advantages that:
(1) according to the invention, by utilizing the characteristic that the Cas9 mutant generates DNA single-strand break, a tracrRNA/crRNA binary complex or an sgRNA is used for generating DNA single-strand nick aiming at each targeting site, and DNA double-strand break is not generated, so that single-strand nick homologous recombination repair is induced, and insertion deletion mutation brought by HMEJ repair is reduced.
(2) The invention combines CRISPR/Cas9 gene editing technology with traditional ES targeting, firstly uses ES cells (embryonic stem cells) to test the sgRNA cutting efficiency, and screens out the high-efficiency sgRNA. And then Cas9 mutant protein and the screened high-efficiency sgRNA of the targeted recombination site are added in the ES targeting process, so that the targeting efficiency can be obviously improved.
(3) The invention utilizes CRIPSR/Cas9n mediated ES targeting gene editing technology, combines protein obtained by in vitro expression and efficient sgRNA obtained by ES cell screening to realize genome multi-site targeting, cuts a plurality of sites on a target gene, improves targeting efficiency while not increasing the length of a homologous arm, realizes the purpose of genome modification, and can be widely used for preparing gene targeting animal models as a platform technology.
Drawings
FIG. 1 alignment of sgRNA cleavage T7EN1 in example 1.
FIG. 2. example 1WT Cas9 mediated ES targeting PCR assay target clone map.
FIG. 3. example 1Cas9n D10A mediated ES targeting PCR assay target clone map.
FIG. 4 target clone map in example 1WT or D10A Cas9 mediated ES targeting Southern assay.
Fig. 5 alignment chart for sgRNA cleavage sequencing in example 2.
FIG. 6 is a graph of target clones in PCR assay of example 2.
FIG. 7 is a map of target clones in Southern assay of example 2.
FIG. 8 is a genotype test chart for the mouse of example 2.
Fig. 9 alignment chart for sgRNA cleavage sequencing in example 3.
FIG. 10 is a graph of target clones in PCR assay of example 3.
FIG. 11 is a map of target clones in Southern assay of example 3.
FIG. 12 genotype test for mice of example 3.
Detailed Description
The following examples illustrate specific steps of the present invention, but are not intended to limit the invention.
Terms used in the present invention generally have meanings commonly understood by those of ordinary skill in the art, unless otherwise specified. The present invention is described in further detail below with reference to specific examples and with reference to the data. It will be understood that this example is intended to illustrate the invention and not to limit the scope of the invention in any way.
In the following examples, various procedures and methods not described in detail are conventional methods well known in the art.
The present invention is further illustrated by the following specific examples.
Example 1 preparation of Prkaa1-KI ES cells
The WT Cas9 and Cas9n D10A used in the present invention, which were purchased from Qiang Biotechnology, Inc., Suzhou, were tested for nuclease activity and used in subsequent experiments.
Design and preparation of sgRNA and detection of cleavage activity
1. Design and preparation of sgRNA for target site
1) Design of sgrnas for sites of interest using Cas9sgRNA design website
sgRNA specificity was analyzed using the website http:// criprp. mit. edu/. Sgrnas with scores of 60 or more were selected, with higher scores indicating higher sgRNA specificity and smaller corresponding off-target effects.
Because the two ends of the homologous DNA donor fragment are respectively provided with homologous arms with the size of about 5kb, the integral skewness is longer, and 1 cleavable sgRNA is respectively designed and screened within 100bp of 2 homologous arms.
The sgRNA sequence is as follows:
sgRNA name Sequence of PAM
Prkaa1-5S1 gaacacuagugcacuuaucc(SEQ ID NO:1) CGG
Prkaa1-3S2 uccugaaaugacuucuggug(SEQ ID NO:2) CGG
2) Designing an sgRNA primer;
the sgRNA sequence was ordered as a forward primer and the reverse complement of the sgRNA sequence was ordered as a reverse primer.
3) Constructing an sgRNA transcription vector;
and annealing the forward primer and the reverse primer to form a double strand, and connecting the double strand with a BsaI single-enzyme digested pUC57-T7 vector to construct a transcription vector containing the sgRNA sequence.
4) Preparing an in vitro transcription template by PCR amplification;
PCR was performed using PrimerStar Max system, sgRNA-F, sgRNA-R as primers, and pUC57-sgRNA plasmid with correct sequence as template, at 95 ℃ for 5min, 95 ℃ for 30s, 58 ℃ for 30s, 72 ℃ for 40s, 72 ℃ for 5min, 30 cycles.
And (4) after the program is finished, carrying out agarose gel electrophoresis, cutting a target band, carrying out gel recovery, and recovering the obtained final product as a transcription template.
2. In vitro transcription using transcription templates and purification
Reagent I: HiScribeTMT7 Quick High Yield RNA Synthesis Kit(NEB#E2050S)
And (2) reagent II: ambion MEGAclear kit (Ambion AM1908)
Press HiScribeTMThe manual of T7 Quick High Yield RNA Synthesis Kit (NEB # E2050S) was used for RNA in vitro transcription and RNA purification according to the manual of Ambion MEGAclear Kit (Ambion AM 1908).
The concentration of the recovered RNA was measured by UV spectrophotometry, and 9. mu.l of 1 × Loading buffer was added to 1. mu.l of RNA sample, followed by agarose gel electrophoresis, and the remaining RNA samples were stored at-80 ℃.
3. The sgRNA and the WT Cas9 protein are transferred into mouse ES cells by electrotransformation
1) Preparation of ES cells were thawed from frozen ES cells in liquid nitrogen, expanded by passage, and counted one day before electroporation to inoculate 5 × 106 cells per 10cm dish.
2) Preparing an electrotransformation sample: cas9 was mixed with sgrnas as electrotransfer samples at 14:00 pm on the day of electrotransfer under RNA-free conditions, according to the electrotransfer requirements.
3) Cell electric transfer, after the cell digestion inoculated in the previous day is stopped, 1 × 106 cells are taken, centrifuged for 5min at 1000rpm, the supernatant is sucked off at negative pressure, 100 mul of electric transfer buffer is used for re-suspending, the mixed electric transfer sample is added, the mixture is transferred into an electric cup after being mixed evenly, after the electric transfer, 500 mu lES-DMEM is added into the electric cup, and the mixture is transferred into a 6-hole plate paved with gelatin.
4) And after 48h, collecting cells, and improving the DNA identification and cutting effect.
4. And (4) carrying out gene identification to obtain the sgRNA with high cutting efficiency.
The PCR system was loaded as in Table 1, the PCR primers are shown in Table 2, and the PCR program is shown in Table 3. The PCR product was digested with T7EN1, and the digestion results are shown in FIG. 1. In fig. 1, the left graph is a graph comparing the cleavage of sgrnas detected in the 5-end homology arm, and the right graph is a graph comparing the cleavage of sgrnas detected in the 3-end homology arm, which shows that 2 bands appear after T7EN1 enzyme digestion, indicating that the sgrnas detected in the 5-end homology arm and the sgrnas detected in the 3-end homology arm can cleave the target genome.
Table 1:
Figure BDA0001906808600000071
table 2:
Figure BDA0001906808600000081
note: the 1 and 2 primers are amplification primers containing the positions of 5-end sgRNA and 3-end sgRNA, respectively.
Table 3:
Figure BDA0001906808600000082
secondly, positive ES clones are obtained by screening through a Cas9D10A mediated ES targeting technology (meanwhile, WT Cas9 mediated ES targeting is used as a control)
i. Feeder cells were plated in 6cm dish one day before electroporation.
And ii, placing the required ES-DMEM, ES-0 and pancreatin in a 37-degree water bath kettle for preheating on the day of the experiment. The electrotransfer instrument is turned on and the parameters are set according to the cell line.
Digesting the cells with pancreatin, neutralizing with ES-0, centrifuging at 1000rpm for 5min, connecting the sterilized suction tube with the soft tube part of an electric suction apparatus (the suction tube is put into a clean bench in advance), and sucking the supernatant under negative pressure.
Using Ca2+/Mg2+free PBS 20ml resuspension, counting, 2 × 106 cells, centrifugation 1000rpm5min, negative pressure suction supernatant.
v. after resuspension with 100. mu.l electrotransfer buffer, the mixed Cas9D10A protein and sgRNA and homologous DNA donor (sequence shown in SEQ ID NO:7, homologous DNA donor contains knock-in site homology arm, replacement CDS, resistance selection element (G418), mixing and transferring into an electric cuvette.
After electroporation 500. mu. lES-DMEM was added to the cuvette and transferred to 6cm dish plated with feeder cells.
After vii.48h, it was replaced with fresh ES-M + G418 containing 200ug/ml G418. Placing into carbon dioxide incubator at 37 deg.C and 5% CO2Culture and screening for 7 days.
After 7 days, single clones were picked into feeder-plated 96-well plates and when ES cells grew to 80% confluency, the cells were plated at a rate of 1: passage 3, one of the plates was used for DNA extraction and the other two plates were used in a freezer frozen to-80 ℃.
ix.96 well plate DNA was identified by PCR.
x.96 well plate cell expansion: after the PCR positive clone is confirmed, the 96-well plate is taken out from a refrigerator with the temperature of-80 ℃, the surface of the 96-well plate is sprayed with alcohol, the 96-well plate is wiped clean, the 96-well plate is placed in an incubator for about 30min, the placing position of the 96-well plate is changed (the 96-well plate which is not completely melted is changed for 2-3 times, the temperature of the bottom of the 96-well plate is lowered after the 96-well plate is placed in one position for 10 min, the bottom of the 96-well plate can be maintained at 37 ℃ again by moving the position so as to be rapidly melted), after all the ice crystals are melted, all the cells are sucked into a 24-well plate, each. Each clone was amplified to 2 10cm dis by changing the medium, passaging, etc., one dish for cryopreservation and one dish for DNA extraction.
Southern identification and karyotype detection: the amplified cell DNA is used for southern detection, and the clone passing the identification is the targeting positive clone.
PCR detection system and results:
PCR system as in Table 4, PCR primers as in Table 5, and PCR program as in Table 6.
Table 4:
Figure BDA0001906808600000091
table 5:
Figure BDA0001906808600000092
note: the 5 'LR-PCR primer is an amplification primer spanning 5-terminal homologous sequences, and the 3' LR-PCR primer is an amplification primer spanning 3-terminal homologous sequences.
Table 6:
Figure BDA0001906808600000101
the results of target cloning in the WT Cas 9-mediated ES targeting PCR assay are shown in fig. 2, where: b6 is a negative control, which is B6 genomic DNA; n is blank control, no template control; p is a positive control; TRANS 2K band: 8000bp \5000bp \3000bp \2000bp \1000bp \750bp \500bp \250bp \100 bp; A1-H6 are samples of different clone numbers. The positive clone amplified by the 5 'LR-PCR is matched with the positive clone amplified by the 3' LR-PCR in number, and the positive clone is correctly recombined. Positive clones were obtained from 48 clones numbered A1-H6: e1, H2, E3, H3, H4, E6; the positive rate is as follows: 6/48% the remainder was wild type or negative.
The results of target cloning in Cas9n D10A-mediated ES targeting PCR assay are shown in fig. 3, where: b6 is a negative control, which is B6 genomic DNA; n is blank control, no template control; p is a positive control; TRANS 2K band: 8000bp \5000bp \3000bp \2000bp \1000bp \750bp \500bp \250bp \100 bp; A1-G4 are samples of different clone numbers. The positive clone amplified by the 5 'LR-PCR is matched with the positive clone amplified by the 3' LR-PCR in number, and the positive clone is correctly recombined. Positive clones were obtained from 40 clones numbered a 1-G6: a1, A3, a5, a6, B1, B3, B4, B5, B6, C3, C5, C6, E1, E3, F2, F4, F5, F6, G1, G2, G3; the positive rate is as follows: 21/40% 52.5% remaining wild type or negative.
And (4) conclusion: comparing the PCR identification results of FIG. 2 and FIG. 3, it was shown that CIRSRD10A mediated PRKAA1 gene recombination more efficiently than WT protein.
Southern detection and results:
the cleavage protocol is shown in Table 7, the probe primer details are shown in Table 8, and the template was a mouse BAC: RP23-240A 23. Table 7:
Figure BDA0001906808600000102
note: the difference between the target genotype and the wild type is distinguished by means of enzyme digestion to produce different fragments.
Table 8:
Figure BDA0001906808600000111
note: primers 1 and 2 are amplification primers of 5-end and 3-end probes respectively, are placed on the outer sides of respective homologous arms, detect a target band, and eliminate random insertion interference.
The results of target cloning in WT or D10A Cas9 mediated ES targeting Southern assay are shown in FIG. 4, in which: B6N is a negative control, and is B6 genomic DNA; marker strip: 15000bp \10000bp \7500bp \5000bp \2500bp \1000bp \250 bp; : a non-destination strip. The results show that: by using the Cas9n D10A protein, the genome is not fractured, and the detection band only comprises a Target band and a WT band; using the Cas9WT protein, DSBs appeared in the genome, with non-Target bands in addition to Target and WT bands.
Example 2Cas9n D10A mediated ES targeting technology CD27-KI mouse model
Design and preparation of sgRNA and detection of cleavage activity
Sgrnas were designed, prepared, and cleavage activity was examined with reference to the method of example 2.
The sgRNA sequence is as follows:
sgRNA name Sequence of PAM
CD27-5S1 uggcauggccaccucccuac(SEQ ID NO:16) TGG
CD27-3S2 acgggcaagagcacaccg(SEQ ID NO:17) AGG
The PCR system was loaded as in Table 9, the PCR primers are shown in Table 10, and the PCR program is shown in Table 11.
Table 9:
Figure BDA0001906808600000112
table 10:
Figure BDA0001906808600000121
note: the 1 and 2 primers are amplification primers containing the positions of 5-end sgRNA and 3-end sgRNA, respectively.
Table 11:
Figure BDA0001906808600000122
the sgRNA cleavage sequencing alignment results are shown in fig. 5, where: the left figure is a graph comparing the cutting of sgRNA measured in a 3-end homologous arm, the right figure is a graph comparing the cutting of sgRNA measured in a 5-end homologous arm, and the black area is a sgRNA sequence. Sequencing alignment shows that double peaks appear at the sgRNA position, which indicates that the position is cut, so that base insertion and deletion are caused, and the sgRNA can cut a target genome.
Screening and obtaining positive ES clone by using Cas9n D10A mediated ES targeting technology
Referring to the method in example 2, positive ES clones were obtained by screening using Cas9n D10A mediated ES targeting technology. The homologous DNA donor sequence is shown in SEQ ID NO. 22.
PCR detection system and results: PCR system as in Table 12, PCR primers as in Table 13, and PCR program as in Table 14.
Table 12:
Figure BDA0001906808600000123
table 13:
Figure BDA0001906808600000131
note: the 5 'LR-PCR primer is an amplification primer spanning 5-terminal homologous sequences, and the 3' LR-PCR primer is an amplification primer spanning 3-terminal homologous sequences.
Table 14:
Figure BDA0001906808600000132
the results of the target clones in the PCR assay are shown in FIG. 6, where: 129 and B6 are negative controls, are 129 and B6 genomic DNA; n is blank control, no template control; p is a positive control; TRANS 2K band: 8000bp \5000bp \3000bp \2000bp \1000bp \750bp \500bp \250bp \100 bp; A1-G12 are samples of different clone numbers; the positive clone amplified by the 5 'LR-PCR is matched with the positive clone amplified by the 3' LR-PCR in number, and the positive clone is correctly recombined. Positive clones were obtained from 96 clones numbered A1-P6: a3, F3, G3, E5, C6, E6, F10, G11, positive rate: 8/96% 8.3%, the remainder being wild type or negative.
Southern detection and results:
the cleavage protocol is shown in Table 15, the probe primer details are shown in Table 16, and the template is a mouse BAC: RP23-394N 13.
Table 15:
Figure BDA0001906808600000133
note: the difference between the target genotype and the wild type is distinguished by means of enzyme digestion to produce different fragments.
Table 16:
Figure BDA0001906808600000141
note: primers 1 and 2 are amplification primers of 5-terminal and 3-terminal probes respectively, are placed on the outer sides of respective homologous arms, detect a target-in-band, exclude random insertion interference, and 3 is an inner primer, and verify the integrity of a target-in-band region.
The results of the target clone in the Southern assay are shown in FIG. 7, in which: B6N is a negative control, and is B6 genomic DNA; marker strip: 15000bp \10000bp \7500bp \5000bp \2500bp \1000bp \250 bp; the LR-PCR positive cloned DNA uses the enzyme cutting scheme and the corresponding probe in the table above, the detected band is referred to the negative control and the Marker band, and the positive clone with the recombination target at the two ends and the integrity passing is judged.
The Southern identification results show that: a3, C6, E6, F3, G3, G11: positive clones passed for targeting and integrity, but random insertions were present in E5, the target band in A3 was weak, and injection was not recommended.
Thirdly, carrying out positive ES clone injection and transplantation
i. Preparation of 2.5 day recipient mice: and (3) selecting ICR female mice with qualified body weight in week age, combining the ligated male mice and the female mice at a ratio of 1:2 at 3:30 in the afternoon, starting to detect embolisms of the receptor at 8:00 in the morning on the next day, marking the embolisms as 0.5 day, and taking the mice with embolisms for 2.5 days as the receptor of the embryo transplantation experiment on the same day.
Preparation of 3.5 day embryos: selecting suitable week-old female mice, performing superovulation (injecting PMSG and HCG), closing ligated male mice and female mice at a ratio of 1:2 at 3:30 in the afternoon, detecting embolus in recipients at 8:00 in the morning on the next day, marking the infected mice as 0.5 day, killing donor mice with embolus for 2.5 days after cervical vertebra is removed, cutting uterus and oviduct, flushing oviduct and uterus from the orifice of the oviduct with an injection needle with D-PBS, selecting embryos at 8 cell stage, cleaning, transferring to a culture dish with M16 liquid drop prepared 1 hour in advance, placing into a culture dish with 37 ℃ and 5% CO, and placing2The incubator was incubated overnight.
injection cell preparation, providing positive ES cells to the injecting person 10:00 a.m. the day of injection, according to the injection requirements.
injection: preparing proper fixed tubes, injection needles and operating dishes, selecting 10-15 small and bright ES cells with smooth edges by using the injection needles, fixing the embryos by using the fixed tubes, slightly rotating the embryos by using the injection needles, searching the intercellular spaces, inserting the injection needles, and slightly blowing the ES cells into the cystic cavities after the injection needles enter the cystic cavities. The blastocysts injected with ES cells were transferred to ES-medium and cultured for 3-4 hours for recovery.
v. embryo transfer: after the blastocyst is fully recovered, the embryo is transferred into E2.5 day recipient uterus. Mice that had undergone the transplantation procedure were placed in clean mouse cages and incubated on a 37 ℃ hot table until the mice were awake. The mice after revival are transferred to the corresponding animal feeding rooms to wait for the birth of a newborn animal.
Breeding the mice: the mouse born by the transplant recipient is marked as a chimeric mouse, male mice with the fur color chimerism rate of more than 50 percent are bred, and the mouse of the offspring is marked as F1. And (3) making a breeding plan according to the breeding target, breeding 3-5F 1 with the genotype meeting the requirement according to the plan, and establishing a line.
And (3) identification: performing tail shearing within 1 week after birth of an F1 mouse, identifying the genotype, and detecting mutation; all mice generated in the process of establishing the strain are subjected to genotype identification so as to ensure the genetic stability of the mouse genes.
PCR system and procedure are shown in Table 17, PCR primers are shown in Table 18, and mouse rat tail DNA is used as a template for identification.
Table 17:
Figure BDA0001906808600000151
table 18:
Figure BDA0001906808600000161
note: identifying KI and KIN as target genotypes; WT was identified as wild type.
The results of mouse genotype detection are shown in FIG. 8, where: the number is the mouse tail number, P is the positive control, WT is the C57BL/6J wild type, N is the negative blank control, M is the DNA Marker band: 8000bp \5000bp \3000bp \2000bp \1000bp \750bp \500bp \250bp \100 bp. Mice # 107, # 108, # 110, # 112 were KI positive F1 mice.
Example 3Cas9n D10A mediated ES targeting technology preparation of Anxa8-CKO mouse model
Design and preparation of sgRNA and detection of cleavage activity
Sgrnas were designed, prepared, and cleavage activity was examined with reference to the method of example 2.
The sgRNA sequence is as follows:
sgRNA name Sequence of PAM
Anxa8-5S1 caaguguguaagacga(SEQ ID NO:39) GGG
Anxa8-3S1 ucuggucagucagcgug(SEQ ID NO:40) GGG
The PCR system was loaded as in Table 19, the PCR primers are shown in Table 20, and the PCR program is shown in Table 21.
Table 19:
reagent Volume (μ l) Specification of
10X Buffer 2.5
ddH2O 17.75
primer 0.5 10uM
primer 0.5 10uM
Mg
2+ 2 25mM
dNTPs 0.5 10mM each
Taq 0.25 5U/μl
Template
1
Table 20:
Figure BDA0001906808600000171
note: the 1 and 2 primers are amplification primers containing the positions of 5-end sgRNA and 3-end sgRNA, respectively.
Table 21:
Figure BDA0001906808600000172
the sgRNA cleavage sequencing alignment results are shown in fig. 9, where: the left figure is a graph comparing the cutting of sgRNA measured in a 3-end homologous arm, the right figure is a graph comparing the cutting of sgRNA measured in a 5-end homologous arm, and the black area is a sgRNA sequence. Sequencing alignment shows that double peaks appear at the sgRNA position, which indicates that the position is cut, so that base insertion and deletion are caused, and the sgRNA can cut a target genome.
Secondly, screening and obtaining positive ES clones by using Cas9D10A mediated ES targeting technology
Referring to the method in example 2, positive ES clones were obtained by screening using Cas9n D10A mediated ES targeting technology.
The homologous DNA donor sequence is shown in SEQ ID NO: 45.
PCR detection system and results:
PCR system as in Table 22, PCR primers as in Table 23, and PCR program as in Table 24.
Table 22:
Figure BDA0001906808600000173
table 23:
Figure BDA0001906808600000181
table 24:
Figure BDA0001906808600000182
note: the 5 'LR-PCR primer is an amplification primer spanning 5-terminal homologous sequences, and the 3' PCR primer is an amplification primer spanning 3-terminal homologous sequences.
The results of the target clones in the PCR assay are shown in FIG. 10, in which B6 is a negative control and is B6 genomic DNA; n is blank control, no template control; TRANS 2K band: 8000bp \5000bp \3000bp \2000bp \1000bp \750bp \500bp \250bp \100 bp; A1-H12 are samples of different clone numbers; the positive clone amplified by the 5 'LR-PCR is matched with the positive clone amplified by the 3' LR-PCR in number, and the positive clone is correctly recombined. PCR positive clone (3-terminal homology arm internal short primer): b1, C3, F3, D4, a5, E5, F9, B10, D10, E10, E11, C12, positive rate: 12/96% 12.5%, the remainder being wild type or negative.
Southern detection and results:
the cleavage protocol is shown in Table 25, the probe primer details are shown in Table 26, and the template is a mouse BAC: RP23-20D 5.
Table 25:
Figure BDA0001906808600000183
Figure BDA0001906808600000191
note: the difference between the target genotype and the wild type is distinguished by means of enzyme digestion to produce different fragments.
Table 26:
Figure BDA0001906808600000192
note: primers 1 and 2 are amplification primers of probes at the 3-terminal and 5-terminal respectively, are placed on the outer sides of respective homologous arms to eliminate random insertion interference, and 4 is an internal primer to verify the integrity of a target region.
The results of the target clone in the Southern assay are shown in FIG. 11, in which: B6N is a negative control, and is B6 genomic DNA; marker strip: 15000bp \10000bp \7500bp \5000bp \2500bp \1000bp \250 bp; the LR-PCR positive cloned DNA uses the enzyme cutting scheme and the corresponding probe in the table above, the detected band is referred to the negative control and the Marker band, and the positive clone with the recombination target at the two ends and the integrity passing is judged.
The Southern identification results show that: a5, B10, C12, D10, E5, E10, E11: positive clones for hit and integrity pass.
Thirdly, injecting and transplanting positive ES clones;
with reference to the method of example 2, injection and transplantation of positive ES clones, breeding and identification of mice were carried out.
The PCR system and procedure are shown in Table 27, and the PCR primers are shown in Table 28.
Table 27:
Figure BDA0001906808600000193
Figure BDA0001906808600000201
table 28:
Figure BDA0001906808600000202
note: fln and Fl are used for identifying the target genotype; WT was identified as wild type.
The results of mouse genotype detection are shown in FIG. 12, where: the numbers are rat tail numbers, P is a positive control, WT is C57BL/6J wild type, N is negative blank control, M is a DNAmarker Marker band: 8000bp \5000bp \3000bp \2000bp \1000bp \750bp \500bp \250bp \100 bp. 56#, 59#, 62#, 65#, 66#, 72#, 73#, 77#, 80#, 84#, 85#, 87#, 89#, 91#, 92#, 97#, 98#, 102#, 109#, 119#, 120#, 122#, 128 #, 134 #: the mice were positive F1 generation mice.
Sequence listing
<110> Jiangsu Jiejiaokang Biotech limited
<120> method for preparing gene targeting animal model by applying CRISPR/Cas9 mediated ES targeting technology
<160>61
<170>SIPOSequenceListing 1.0
<210>1
<211>20
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>1
gaacacuagu gcacuuaucc 20
<210>2
<211>20
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>2
uccugaaaug acuucuggug 20
<210>3
<211>20
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>3
acttttacct gctgagccta 20
<210>4
<211>22
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>4
gtgtatgtgc taagctagtg gt 22
<210>5
<211>24
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>5
gaactcttga ctggtcactt tttg 24
<210>6
<211>23
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>6
ggccaatgtg ttacttttat gtc 23
<210>7
<211>18829
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>7
ctcctggctt gttttgctct taccttacca taagtgtgcc aagcaggctc ccaactgggc 60
cctggccctg gctgttcctt ccccctgccc acttcacctt cctcctggcc aaggtagtct 120
gctcctccct tccttggggc tctgctctgg tgtactctgt gaccttcctg gcatgctctg 180
cctcttactt aattactgtc tgtgtcctgg cccctgcatc aagaacataa caaacttgct 240
tactgtctgt ctcctggcac ctgcatcagg accataacaa aaacaggaga ttggctttgc 300
tcccccacag acttctagca gctagcacag tacctggtat cttataggtg cttagtaaat 360
ctttactgaa tggatgaata cacgtgtttt aatattagta gataatgttt tctctcacca 420
ggtaccaggt catcagtaca ccatctgata ttttcatggt gatggaatat gtctctggag 480
gagagctatt tgattatatc tgtaaaaatg gaagggtaag cagttctcat ttaattctgt 540
acacagtttg gtaactctct gtccccctta ttgcattata gtgtcagcaa gcaattttca 600
gaggtctgtt tagtaataag tccccttagc atgaatttgt gtagcatcat aggctaatga 660
gaaggaaagg acctcaaaag tgatccctga tcccatttaa ttgacatgga tataaagact720
acttgttgag tatttgttca aggtcacgtg atttactagt gatttacaga gttcacgtaa 780
gtccctaaaa tttattatcc tcagatttaa ggtttttagc aaaacaaact tttatttatt 840
tttttggaga cagggtcaca ctatgccact gtgactgcca tgtagatcag gctggcctcc 900
agtgcatagc catgcccctg tctctgtctc ccaagtgctg ggattgaagg tgtgcctggt 960
ctgtgctcac ccttaatgtg cttcctaaac tttcctaaca cgctttccta tgtgggcctc 1020
ccaaaatacg tcagtaagta cttaaacgat gtaggccttg ttcttcaacc ctggccacat 1080
ttcagttgtg ctcgtgtgtt ggtttctgat gtgcctgcag tagaaaggaa tagggatttt 1140
gaaggagcta ggaagtagac ttacagggct tagtgtttga aggaaccttg aagacgttta 1200
gttctaagca caaattctga gcaccgtccc ctgcccatac gcactctcac gttatctgac 1260
tggcacagcg ccctgctgaa aggccccaca cctaggagag aagagagcct ggctcccctt 1320
cagtcggaag ctatttgcat tcttcattct ttcatgttac gcactgtctc tctttaatca 1380
ggatcagact cattaagcac gctagtctgt tttttctcaa tgtggttaat ttctacctaa 1440
agttttccct ttctcatcct tcaaggccct attcctgtcc actggaggaa ttcttccaaa 1500
ttgatcaatg cctgcatttc tcatctctct ctttttttcc tcccatttgt catttctagt 1560
cattttgcta tacattgtgg ggacgtcttt agtgttacct tttgaatgcc aaccttccag 1620
ctgtcacatg tttgtatttc agatttctgc cttattttct gaaattccct ttggatagct 1680
gcctgtttgg ccttacctgt ttgagaatga cattttggtt ttaaatgtct tttggccact 1740
gcaccgctcc gttttccgtg ctttccgctc gcctcctctt ttttttcccc ccttctgttc 1800
attttgtctc cccccccccc aaccctccca tactcttagt cagatatctg gccattctta 1860
gctgtccact taaatttcag aacaaagtca caccacatgc caagccagtg gatgtgtgct 1920
gtttatggtt ttccctcagg ttgcattgtt ggagacatta attttggtag ggtaaattct 1980
ttgctcacaa gcacaagtgt ttttcttcgt ttgatttggt atctgctttt tcctattttc 2040
ttgaaggtat tggtttagct gttggaactg agtcgggaga tggggtcagg tctttcctgt 2100
tagtatgcac ataatctaca tcttccttaa cggcctggcc aacccgagga gctacaggtc 2160
ttactccccc ttggtggtac ctacagcttt ctgcacaggc ctgctgtctt gtttccgtcc 2220
gcccctcatt gcttcagaaa gtcatggtgc acccactgct cagcgttccc agggttccgc 2280
tgtgcacttg cgttcatttt ctcctctagg atttggtttt gcttttctct cttttgctga 2340
gttttcatct gctgtccata cattcctctt gatggccgct gtctctccat ctttttgttt 2400
tatgggcctt gtgtgttgct gacagcaccc tggggcgaca caacagggag tgacacaaaa 2460
gactcagtgt gggatgttta tcagcttgga gtgttctttt acatggctca tcttccttta 2520
gtcgctgcca ttctttgtac tgtattttta taaataaaat tcttttcacc tttgcagcct 2580
ttctgttact tatcatttgt taagttttct cttcctcttg cataattttt ttttaaataa 2640
acatctactt gaacaaaggt gtgagattgc aaaagtatta atgtcttttt cttaagggag 2700
aggaccttac atttcagggt aagggtatgc tacacttcag tagcattttt aattttgtat 2760
tcaaagcaat ggctggtttc tctttgtccc acgttatcca tgcggtgaag gtgtggggtt 2820
ctggatttag aatgctcact cctgacctgc caaggacctc atgtgagcat ccttgcctgg 2880
gccagtagct cacttatcga atcccctgtc ctggaacccg ggcaaagcag tgctgcttcc 2940
cctgctgagc aaacgccaga aaatgcagag actggaagat gatttttaaa agattgtact 3000
taaaaattgt aattgtagtg taagtgtttt ccttcaggaa agatgcaaag ggtaaatgtg 3060
ctaaggattt tcttttggtg aagtgaaaac atcttagacc tgaagagatg gcacccatgt 3120
caggtggctc tcgattgtaa ctccgggtcc agaggaccca acattcttag cattcttgtc 3180
tctgtaggca cctgcaggca gatgcacaca cacacacaca cacacacaca cacacacaca 3240
cacacacaca tatacacaca cacacacata tacacacaca cacacacaca cacatacaca 3300
cacacacata cacacacata cacacacata cacacacaca cacacataca cacacacaca 3360
cacacacaca cacacacaca cacacacact taaaaatagc ttaaatttca gagtacaggc 3420
tatctttgcg ttgtggctca attccaatac ttacctgtca cttctttgtg gtctgtaatc 3480
gtcccccatg caagcatcac ttggtatatt ctctttttct ttcccttttc tccgattaga 3540
tttgctcttt gacagttgcg tccatgtgtt ctgcgccctc tgtgtacgct cccaccctga 3600
cccccttctc ttccttcccc tcctccctgc aggtccctgg tttacactca tgactttgtt 3660
ctgttctggg aaccactgag tttgactaga agcatctgtt tccccctggg tttggatctg 3720
ctcattggaa cgctttctgt atcactctgt gacccttttt tcccactgtt acgctcatgt 3780
ttggtttggt tttggcctta ttttgtctac tagagtaggg ccttcctctc actcatctct 3840
gtgctatgga tatctaacca gtacagcata ttgaatatct aatactatgg atatctaacc 3900
agtacagcat attgaatgtg ctcagtaaat atttgttgaa ggagggaagg attaaacacc 3960
actaattgga aaacattccc agtttcaggt agaagttgaa agtactagaa atagcccatg 4020
agctccagaa gaagatgtgt ttttaagtgt agtttatata tgtgataggg tcaaagagtt 4080
gagttgctga tttggtcccc gtaagccctt gcttggcatt tcagtgtagg gctgcaggcc 4140
ttacttgccc atttcaaagt acctcatggg tgaagttcgc ctggaagctt tcaggcgttg 4200
acagtccaca ggctggagaa ttataagaat gttttcattg agagacacag cttaaaatgc 4260
ctttcttctt ttcctagttg gacgaaaagg aaagccgccg tctgttccag cagatccttt 4320
ccggtgtgga ttattgtcac aggcatatgg tggtccacag agatttgaaa cctgagaacg 4380
tcctgcttga tgcacacatg aatgcaaaga tagccgactt tggtaaggat ggttgtgatg 4440
tttaatgagc ataagtatca tcttctggta gtgtttatgg ggtgcactag aaccccactc 4500
tgcaagtgaa cattcagaag ggaaaacagt aaggtacgcg cgcgcgcgcg cgcgcacaca 4560
cacacacaca cacacacaca cacacacaca cacacacaca cgccacagga tagctttggg 4620
ggatgtttct attcttccag cacgtgggtc ttagagggtg gatttaggtt gtcaggcatg 4680
gtggtaagca cttttacctg ctgagcctac ctgccagccc tgaaattcag ttttgtgatc 4740
ttaaatattt caacttctta acattagaga gatcatttga aaagaaaaga ctattatttg 4800
tcaagaaggt agcaacttga tttctaatat ttctttttgg tggagtatgg agaaaatgga 4860
aagtgggatg gaattattga cataacattg gaatctagaa agatgaatta tatgaggaaa 4920
ctttttttat aaaattaata tttaaatgct gtaaagttgg ttttcagatg tagtggtagg 4980
tgccttcagt ctaagaattc cagagatgga ggccgataac ttcgtatagc atacattata 5040
cgaagttatg tagagatctt tctgttcagc tgggtctatt ttgcctagca gtatccatat 5100
taaaaggtag acatttcaag gatcttctag tattcaaaac caccactagc ttagcacata 5160
cacattaaac tctagatgtt gaaattcatt gtacattttg tgtataaggt cagaatattt 5220
aagaaataaa gactataatc aagttaaaag tttttgtttt tttgtttttt ttttctgttt 5280
ttattttatt ttattttatt acatattttc ctcaattaca tttccaatgc tatcctaaaa 5340
gtcccccata ccctcccccc ccacttccct acccactcat tcccattttt tttggccctg 5400
gcgttcccct gtactggggc atataaagtt tgtgtgtcca atgggcctct ctttccagtg 5460
atggccgact agaccatcgt ttgatacata tgcagctaga gtcaagagct ccaggatact 5520
ggttagttca taatgttgtt ccacctatag ggttgcagac ccctttagct ccttgggtac 5580
tttctctagc tcctccattg ggagtttttt tttctgtttt acttgctttt tgtccttaag 5640
aactcttgac tggtcacttt ttgtcatttc aggtctttca aacatgatgt cagatggtga 5700
atttttaaga acaagctgtg gctcacccaa ttatgcagct ccagaagtca tttcaggaag 5760
attgtacgca ggccccgagg tggacatctg gagcagcggg gtcattctct atgctttgct 5820
gtgtggaacc ctcccttttg atgatgacca tgtgccaact ctttttaaga agatatgtga 5880
tgggatcttt tatacccctc agtacttaaa cccttcagta atcagccttt tgaaacatat 5940
gctgcaggtg gatcccatga agagggccgc aataaaagat atcagggaac acgagtggtt 6000
taaacaggac cttccgaagt atctctttcc tgaggaccca tcttatagtt caaccatgat 6060
cgatgacgaa gccttgaaag aagtgtgtga gaagttcgag tgttcggagg aggaggtcct 6120
cagctgcctg tacaacagaa accaccagga cccactagcc gtcgcctacc acctcatcat 6180
agacaacagg agaataatga atgaagccaa agatttctac ctagcaacca gcccacctga 6240
ctctttcctg gacgaccacc atttaactcg gcctcaccct gaaagagtac cgttcttggt 6300
tgccgaaaca ccacgggccc ggcacaccct ggatgaatta aacccacaga aatccaaaca 6360
ccaaggtgta cggaaggcaa aatggcattt gggaattcga agtcaaagcc gacccaatga 6420
tatcatggca gaagtttgta gagcaatcaa gcagttggat tatgaatgga aggttgtaaa 6480
cccctattat ttgcgtgtac gaaggaagaa tcctgtgaca agcacatttt ccaaaatgag 6540
tctacagcta taccaagtgg atagtaggac ttacttgttg gatttccgta gtattgatga 6600
tgagattaca gaagccaaat cagggactgc tactccacag agatcgggat ccatcagcaa 6660
ctatcgatct tgccaaagga gtgactctga tgccgaagct caaggaaagc cctcagacgt 6720
ctcccttacc tcatctgtca cctccctcga ctcctcccct gtcgacgtag ctccaagacc 6780
aggaagtcat acaatagaat tttttgaaat gtgtgcaaat ctaattaaaa ttcttgcaca 6840
gtaactgtaa gtctgcagaa attgatgatc tattaaacaa taaagatgtc cactaaaatg 6900
gaagtttttc ctgtcatact ttgttaagaa gggtgagaac agagtaccta cattttgaat 6960
ggaaggattg gagctacggg ggtgggggtg gggtgggatt agataaatgc ctgctcttta 7020
ctgaaggctc tttactattg ctttatgata atgtttcata gttggatatc ataatttaaa 7080
caagcaaaac caaattaagg gccagctcat tcctcccact catgatctat agatctatag 7140
atctctcgtg ggatcattgt ttttctcttg attcccactt tgtggttcta agtactgtgg 7200
tttccaaatg tgtcagtttc atagcctgaa gaacgagatc agcagcctct gttccacata 7260
cacttcattc tcagtattgt tttgccaagt tctaattcca tcagaagctt gcagatctgc 7320
gactctagag gatcgactgt gccttctagt tgccagccat ctgttgtttg cccctccccc 7380
gtgccttcct tgaccctgga aggtgccact cccactgtcc tttcctaata aaatgaggaa 7440
attgcatcgc attgtctgag taggtgtcat tctattctgg ggggtggggt ggggcaggac 7500
agcaaggggg aggattggga agacaatagc aggcatgctg gggatgcggt gggctctatg 7560
gctgcgactc tagaggatca taatcagcca taccacattt gtagaggttt tacttgcttt 7620
aaaaaacgtt taaacctccc acacctcccc ctgaacctga aacataaaat gaatgcaatt 7680
gttgttgtta acttgtttat tgcagcttat aatggttaca aataaagcaa tagcatcaca 7740
aatttcacaa ataaagcatt tttttcactg cattctagtt gtggtttgtc caaactcatc 7800
aatgtatctt atcatgtctg gatctgcgac tctagaggat cataatcagc cataccacat 7860
ttgtagaggt tttacttgct ttaaaaaacc tcccacacct ccccctgaac ctgaaacata 7920
aaatgaatgc aattgttgtt gttaacttgt ttattgcagc ttataatggt tacaaataaa 7980
gcaatagcat cacaaatttc acaaataaag catttttttc actgcattct agttgtggtt 8040
tgtccaaact catcaatgta tcttatcatg tctggatctg cgactctaga ggatcataat 8100
cagccatacc acatttgtag aggttttact tgctttaaaa aacctcccac acctccccct 8160
gaacctgaaa cataaaatga atgcaattgt tgttgttaac ttgtttattg cagcttataa 8220
tggttacaaa taaagcaata gcatcacaaa tttcacaaat aaagcatttt tttcactgca 8280
ttctagttgt ggtttgtcca aactcatcaa tgtatcttat catgtctggatccccatcaa 8340
gctgataaca tacgctctcc atcaaaacaa aacgaaacaa aacaaactag caaaataggc 8400
tgtccccagt gcaagtgcag gtgccagaac atttctctaa ggcgcataac gataccacga 8460
tatcaacaag tttgtacaaa aaagcaggct ggcgccggaa cgcatgcaga tctacgcgtg 8520
attaacttta aataattggc attatttaaa gttattaatt aaccccccca aaaaaaaggt 8580
gcctatcacc cttctgccta cctgtgtatc ctcaggacat ggtgggcctc tctggttggc 8640
agaaagcaca acaaagcctc ttcatcctat actacttctc ttgaccagat gccaagtcta 8700
atatgaactg caatcctcta tacaccaaaa gttcatgggg gcaccgtgag gtcccactcc 8760
acctcagcca attccttgtt gctgccccac tcacctcctg agcctccctc tgtttcctgt 8820
ccacctttca gcttccctct caggctggga gcaggggcca gtagcagcac ccacgtccac 8880
cttctgtcta gtaatgtcca acacctccct cagtccaaac actgctctgc atccatgtgg 8940
ctcccattta tacctgaagc acttgatggg gcctcaatgt tttactagag cccacccccc 9000
tgcaactctg agaccctctg gatttgtctg tcagtgcctc actggggcgt tggataattt 9060
cttaaaaggt caagttccct cagcagcatt ctctgagcag tctgaagatg tgtgcttttc 9120
acagttcaaa tccatgtggc tgtttcaccc acctgcctgg ccttgggtta tctatcagga 9180
cctagcctag aagcaggtgt gtggcactta acacctaagc tgagtgacta actgaacact 9240
caagtggatg ccatctttgt cacttcttga ctgtgacaca agcaactcct gatgccaaag 9300
ccctgcccac ccctctcatg cccatatttg gacatggtac aggtcctcac tggccatggt 9360
ctgtgaggtc ctggtcctct ttgacttcat aattcctagg ggccactagt atctataaga 9420
ggaagagggt gctggctccc aggccacagc ccacaaaatt ccacctgctc acaggttggc 9480
tggctcgacc caggtggtgt cccctgctct gagccagctc ccggccaagc cagcggcgcg 9540
ccgccaccat gggtgctagc gagctgatca tctctggctc ctctggagga ttcctgagga 9600
acatcggcaa ggagtaccag gaggctgctg agaacttcat gagattcatg aatgaccagg 9660
gagcctacgc ccctaacacc ctgagagacc tgaggctggt gttccactcc tgggctagat 9720
ggtgccacgc tagacagctg gcctggttcc ctatctctcc tgagatggct agggagtact 9780
tccttcagct gcacgatgct gacctggcct ctaccaccat cgacaagcac tacgccatgc 9840
tgaacatgct gctgtcccac tgtggcctgc ctcctctgtc tgatgacaag tctgtgagcc 9900
tggccatgag gagaatccgg agagaggctg ccaccgagaa gggagagaga accggccagg 9960
ccatccctct gagatgggat gacctgaagc tgctggatgt gctgctgtct agatctgaga 10020
gactggtgga cctgaggaat agggccttcc tgtttgtggc ctacaacacc ctgatgagga 10080
tgtctgagat ctctaggatc agagtgggag acctggacca gaccggagac accgtgaccc 10140
tgcacatctc ccacaccaag accatcacca ccgctgctgg cctggacaaa gtgctgtcta 10200
ggaggaccac cgctgtgctg aatgactggc tggatgtgtc tggcctgaga gagcaccctg 10260
acgctgtgct gttccctcct atccaccgga gcaacaaggc taggatcacc accacccctc 10320
tgaccgcccc tgccatggag aagattttta gcgatgcctg ggtgctgctg aacaagaggg 10380
atgccacccc taacaagggc cgctaccgga cctggaccgg ccactctgct agagtgggag 10440
ctgccatcga catggctgag aagcaagtgt ccatggtgga gatcatgcag gagggcacct 10500
ggaaaaagcc tgagacactg atgagatacc tgaggagggg aggagtgtct gtgggagcca 10560
actctaggct gatggactcc gctagcggcg ccggtcctaa gaagaagagg aaagtgtgag 10620
gccacgtagg cccgcgatga ataaatgaaa gcttgcagat ctgcgactct agaggatctg 10680
cgactctaga ggatcataat cagccatacc acatttgtag aggttttact tgctttaaaa 10740
aacctcccac acctccccct gaacctgaaa cataaaatga atgcaattgt tgttgttaac 10800
ttgtttattg cagcttataa tggttacaaa taaagcaata gcatcacaaa tttcacaaat 10860
aaagcatttt tttcactgca ttctagttgt ggtttgtcca aactcatcaa tgtatcttat 10920
catgtctgga tctgcgactc tagaggatca taatcagcca taccacattt gtagaggttt 10980
tacttgcttt aaaaaacctc ccacacctcc ccctgaacct gaaacataaa atgaatgcaa 11040
ttgttgttgt taacttgttt attgcagctt ataatggtta caaataaagc aatagcatca 11100
caaatttcac aaataaagca tttttttcac tgcattctag ttgtggtttg tccaaactca 11160
tcaatgtatc ttatcatgtc tggatctgcg actctagagg atcataatca gccataccac 11220
atttgtagag gttttacttg ctttaaaaaa cctcccacac ctccccctga acctgaaaca 11280
taaaatgaat gcaattgttg ttgttaactt gtttattgca gcttataatg gttacaaata 11340
aagcaatagc atcacaaatt tcacaaataa agcatttttt tcactgcatt ctagttgtgg 11400
tttgtccaaa ctcatcaatg tatcttatca tgtctggatc cccatcaagc tgatccggaa 11460
ccgcttggct gcaggtcgtc gaaattctac cgggtagggg aggcgctttt cccaaggcag 11520
tctggagcat gcgctttagc agccccgctg ggcacttggc gctacacaag tggcctctgg 11580
cctcgcacac attccacatc caccggtagg cgccaaccgg ctccgttctt tggtggcccc 11640
ttcgcgccac cttctactcc tcccctagtc aggaagttcc cccccgcccc gcagctcgcg 11700
tcgtgcagga cgtgacaaat ggaagtagca cgtctcacta gtctcgtgca gatggacagc 11760
accgctgagc aatggaagcg ggtaggcctt tggggcagcg gccaatagca gctttgctcc 11820
ttcgctttct gggctcagag gctgggaagg ggtgggtccg ggggcgggct caggggcggg 11880
ctcaggggcg gggcgggcgc ccgaaggtcc tccggaggcc cggcattctg cacgcttcaa 11940
aagcgcacgt ctgccgcgct gttctcctct tcctcatctc cgggcctttc gacctgcagc 12000
ctgttgacaa ttaatcatcg gcatagtata tcggcatagt ataatacgac aaggtgagga 12060
actaaaccat gggatcggcc attgaacaag atggattgca cgcaggttct ccggccgctt 12120
gggtggagag gctattcggc tatgactggg cacaacagac aatcggctgc tctgatgccg 12180
ccgtgttccg gctgtcagcg caggggcgcc cggttctttt tgtcaagacc gacctgtccg 12240
gtgccctgaa tgaactgcag gacgaggcag cgcggctatc gtggctggcc acgacgggcg 12300
ttccttgcgc agctgtgctc gacgttgtca ctgaagcggg aagggactgg ctgctattgg 12360
gcgaagtgcc ggggcaggat ctcctgtcat ctcaccttgc tcctgccgag aaagtatcca 12420
tcatggctga tgcaatgcgg cggctgcata cgcttgatcc ggctacctgc ccattcgacc 12480
accaagcgaa acatcgcatc gagcgagcac gtactcggat ggaagccggt cttgtcgatc 12540
aggatgatct ggacgaagag catcaggggc tcgcgccagc cgaactgttc gccaggctca 12600
aggcgcgcat gcccgacggc gaggatctcg tcgtgaccca tggcgatgcc tgcttgccga 12660
atatcatggt ggaaaatggc cgcttttctg gattcatcga ctgtggccgg ctgggtgtgg 12720
cggaccgcta tcaggacata gcgttggcta cccgtgatat tgctgaagag cttggcggcg 12780
aatgggctga ccgcttcctc gtgctttacg gtatcgccgc tcccgattcg cagcgcatcg 12840
ccttctatcg ccttcttgac gagttcttct gagcgggact ctggggttcg aaatgaccga 12900
ccaagcgacg cccaacctgc catcacgaga tttcgattcc accgccgcct tctatgaaag 12960
gttgggcttc ggaatcgttt tccgggacgc cggctggatg atcctccagc gcggggatct 13020
catgctggag ttcttcgccc accccccgga tctaagctct agataagtaa tgatcataat 13080
cagccatatc acatctgtag aggttttact tgctttaaaa aacctcccac acctccccct 13140
gaacctgaaa cataaaatga atgcaattgt tgttgttaac ttgtttattg cagcttataa 13200
tggttacaaa taaagcaata gcatcacaaa tttcacaaat aaagcatttt tttcactgca 13260
ttctagttgt ggtttgtcca aactcatcaa tgtatcttat catgtctgga tccgggcggc 13320
cgctaacttt aaataattgg cattatttaa agttacaccc agctttcttg tacaaagtgg 13380
ttgatatctc tatagtcgca gtaggcgggg taccgctagc ataacttcgt atagcataca 13440
ttatacgaag ttatgtagag atctttctgt tcagctgggt ctattttgcc tagcagtatc 13500
catattaaaa ggtagacatt tcaaggatct tctagtattc aaaaccacca ctagcttagc 13560
acatacacat taaactctag atgttgaaat tcattgtaca ttttgtgtat aaggtcagaa 13620
tatttaagaa ataaagacta taatcaagtt aaaagttttt gtttttttgt tttttttttc 13680
tgtttttatt ttattttatt ttattacata ttttcctcaa ttacatttcc aatgctatcc 13740
taaaagtccc ccataccctc cccccccact tccctaccca ctcattccca ttttttttgg 13800
ccctggcgtt cccctgtact ggggcatata aagtttgtgt gtccaatggg cctctctttc 13860
cagtgatggc cgactagacc atcgtttgat acatatgcag ctagagtcaa gagctccagg 13920
atactggtta gttcataatg ttgttccacc tatagggttg cagacccctt tagctccttg 13980
ggtactttct ctagctcctc cattgggagt ttttttttct gttttacttg ctttttgtcc 14040
ttaagaactc ttgactggtc actttttgtc atttcaggtc tttcaaacat gatgtcagat 14100
ggtgaatttt taagagacag ctgtggctca cccaattatg cagctccaga agtcatttca 14160
ggaaggtatt gctgccatta ggctactttt gatgtgcctg ttgttgctta tttctcttaa 14220
gtttgttagt ctgtactgtc gccttgagga tgtgatgtca ctaacgagga cataaaagta 14280
acacattggc ctgtggtaac tgtcatctcc gaggctcgct gcctcagtct gctaacgtag 14340
gtctaggcct ggaagcttct agcttgtgta caatctaatc taggcctaga aagacttcag 14400
ctgctgaggc ttgctgctgg gtaagcgcgc cccttccttg ttctttctga tctatggctg 14460
attcaactca gatgttttgg ctctcaaact cctctccacg ataactgatt caatctggct 14520
tctctgggct tctcctgaat ttgccctgct tgacctccaa ctctgtcatc gttctaatct 14580
ggctccttct cagtctctgc ttgttctgtc ttcacctgtg tctggcttgt ccttcctctg 14640
caagctgtct ctgtacatct gtcctggtac agtggcctcc tctccctgca ctgaccctca 14700
agtacttcct ctctcttccc gtgagaggtt gggcatatcc tattctgtca ggtctttttc 14760
tgatttgtca tttgtctgcc actcaattag aagttacttt caaacatggg tgctttcttc 14820
tatgaactaa ctttgccaca gggattaaaa gtgtgtgctg aggccgaggc acatcacaac 14880
tagaagcagc tttttcagta aataacacaa tcttgaggtt ttacaatatg ataagatatc 14940
ctgcaacaga aagaagggaa tatatttctg tacttgcaga ttttctattt tatgaataat 15000
cacaaggagc tggagagatg gcttattggt taagaggact tgctgctctt ctagaggact 15060
ggaatttggg acctggcaac cacaatctgg gtggctcaca gttgtctata actttgcctc 15120
caggagaccc aacacactct tggtttttgc aagcagttac atacatggat gcacctcaac 15180
acacacacac acacacacac acacacacac acactaataa taataataat aataataata 15240
ataataataa tagaaataaa taaaaaaaac aagtggaaaa acaagtccat ctttggagga 15300
gagtgttggt ttgcaagtca cagtaaagta gttagaatga agtgctttca tttttgtctc 15360
tggtgggcga attgaaagcc aaccagctgt aaaggtggat aagccgctga gaacctgcct 15420
actgcagtac tcactcccga ggaatgcttt acttaggcga acattaaaaa atgtaacatg 15480
atgggcaatc cttgctggta attctacacc ttctcatgac accatctcaa gaaaaccaaa 15540
ccaaactaga ccgcacagag agcagaacag agttacaagt gtaacgtcac gtgtagttgt 15600
ataagtattc aaatagctgg cattcatgta gtagcttcat gttttatgag gaaggaaact 15660
aaagaagtgg tcctttaaaa aaacagacca gctgaatgta ttgcatgcct atagcctgag 15720
tatcgcacat ggatgccaag acagggctat ataggcctgg tatcaaggaa aatcgaggtg 15780
aggtgagggg caagagggtt ataaaaaggg agaaggaagg agagagactc atttatgttc 15840
agtcttgatc tagatctgct agagattgaa gtgtaagact gctgaactctgaactactat 15900
ctagcactaa aggacggatg tattttcatt agttactttt taaatagcgt gaaaacaaaa 15960
tttaatttgt gttttatttc cttgttttgt tcaaggttca agttcctcct cctcctcctc 16020
tccttcctct ccctcctcct ctccttcctc tccctcctcc tctccttcct ctccctcctc 16080
ctcctcttcc tcctctgtga tagagacagt tcattaacaa agagaaggca cgcctaaatt 16140
tggaagtggg gtagtggtct gggaaaagat atttgcttaa agttgtaaaa tttaatttaa 16200
aagacagact ttattttaaa ccatatatgt atgtgtgttt gtgtgagggt atgtgtacat 16260
tagtgtaggt gctgacagag gtcagagccc cccaacccca cccccccaat cctcaccctt 16320
cagctattgc tacgggcagt tgtaagctgc cttgtgtgtg tgtgtgtgtg gggggggtga 16380
gaactaaacc agggacctct ataaaaacag cgcaggttct caatggctga gacatccctc 16440
cagctcagag aatttattat ttttttccat tttttaaaat taggtattta cttcatttac 16500
atttcaaatg atatcccgaa agtctccaat accctccccc aacctgctcc cctacccacc 16560
cactccccct ttttggccct ggtgttcccc tgtactgggg catataaagt ttgcaagacc 16620
aatgggcctc tcttcccaat gatggccgac taggccatct tctgatacat atgcagctag 16680
aaacacgagc tccggggtac tggttagttc ataatgttgt tccacctata gggttgcaca 16740
ccccttcagc tccttgggta ctttcactgg ctcctctatt gggggccctg tgatccatcc 16800
catagctgac tgtgagcatc cacttctgtg tttgctaggc acccgcatag cctcacaaga 16860
gacagctata tcagggtcct ttcagcaaaa tcttgctggc gtagagaatt tatttttaag 16920
atcaacgctt tggctaggct tggtggtgca ccttacccag gaggttagac agcagtttgt 16980
ctccagctca ggctccttag tgagacaggg ccagcttggg aataaataaa atgctcttgc 17040
aaaaacaagc aagcaaagaa agaaataaaa aacaagtaaa agtcaaagca aacaaaaaca 17100
cattgcttcc tcattgctgc tgaaacacta atgaggtagg ggaggcctgt tgctcgccag 17160
tgcccacaat cccgtccacc tcaaccattt ccttgtttaa atgcttcaaa tggtgatgga 17220
cctaatttaa aaaaaaatcc ctgtgctttc tatgttcatg tgcttatttt tttttgactg 17280
ctcaaagaaa aggtaatgaa gtgaattaaa aagattcatt tgtgttttct atcttaattc 17340
ctttgatttg agaaaaattc aaaatctaga tgctacaggg aatataacta aagaaaaaag 17400
gcatgcgtca tgttcaagca tgcataaaat gggctcttgg ggaaatgtac agtttggatg 17460
tctttccttg aggtctgtgt gaataggagc actcattttg agaacagtgt ttactgctgt 17520
ctataggaag gaagcactct cgtcactctg agggttcgtt ttccccctga aggcagcctc 17580
ggatgattca gctggtttgc agctagttag aatccgtgtc tccagtgctt ccttcacgta 17640
gacgcactca cgcacgaaga gggcgagtgt tctgtgagct ccactgccct tggcttgctt 17700
ctgcagctcc agcttcctga actgtgatgt gagggtttta ggagaaatgg gttcagagtc 17760
tgtcactaca gacttgaatc atgggcccag cgagttggct cagctggtaa aacatttgct 17820
gccaagtgcc tagagtctga cccctgaatc ctgggtaaag gtaggagaga actgattcca 17880
cagagctgtc atctcagctc cacacccact gtggcatgtg cacaccatac acacgcacat 17940
gcatgtgcac acacacacac acacacacac acacacacac actaaaagtt acttaaaggt 18000
gagggtgggg gaacaaaaaa ggtacttaaa aaaaactatc cctgtggctc aaatcaacat 18060
tgatcatgat ggctcaaggg ttgaccttat tggtaggaag tttgagggtc atagtaaggt 18120
agtacaattt gacccatgga tcacaagtta caaaatagct tatttttaaa caggtaatac 18180
tgataagact agtatcttta tgtgtgatgt gcaacaacca ctatagatac catattctga 18240
ccactgattt ctttaaaaat tattttctta tatttttcat aaagtatttg tatttgaaga 18300
gtgttgaccg atgctttttg atattgtgat taatacagtt agcattctct atgcagattg 18360
tacgcaggcc ccgaggtgga catctggagc agcggggtca ttctctatgc tttgctgtgt 18420
ggaaccctcc cttttgatga tgaccatgtg ccaactcttt ttaagaagat atgtgatggg 18480
atcttttata cccctcagta cttaaaccct tcagtaatca gccttttgaa acatatgctg 18540
caggtggatc ccatgaagag ggccgcaata aaagatatca ggtaactcac tttatctgcc 18600
tacttgacca accagccaac aaaccatctg tctgtctgtc tgtctgtctg tctggactgt 18660
gtagtcttgg ctatcctgga actcactcta aagacaaggc tggccctgcc tccctctgcc 18720
acccgagtgc agtgctagga ttaaaggcgc gtggtattac cattgcacag caatattagg 18780
tgatttttaa accaatgtat ttttctacct tttcgagtct ctagatacc 18829
<210>8
<211>22
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>8
ggtcttcata ccgccactgc tt 22
<210>9
<211>21
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>9
ggcctgcgta caatcttcct g 21
<210>10
<211>25
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>10
cacccagctt tcttgtacaa agtgg 25
<210>11
<211>25
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>11
gcacagctgc cactatcagt catgc 25
<210>12
<211>23
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>12
ccttcggtgt taccttgtag gct 23
<210>13
<211>21
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>13
tctggaggaa gagatggagt g 21
<210>14
<211>20
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>14
cccttcttcc accattgctg 20
<210>15
<211>21
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>15
ccattttgcc ttccgtacac c 21
<210>16
<211>20
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>16
uggcauggcc accucccuac 20
<210>17
<211>18
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>17
acgggcaaga gcacaccg 18
<210>18
<211>22
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>18
catgtctgtg aagctcagca ga 22
<210>19
<211>21
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>19
gaatgtacct gagagcagag g 21
<210>20
<211>22
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>20
tctgtagccc tcacattcag ag 22
<210>21
<211>23
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>21
tctgtgcaaa cacaatcggt cag 23
<210>22
<211>21864
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>22
agcatgttca acgcagtgag ccacctctgc tgcctccatc caccgatgca atgcatcggt 60
ccagcgccca ggtaaactgc tgccccttca tctccactcc ttgcgacttg cagactcaag 120
taccagtgaa ggggaaaagg cacaagtatc ctctgagccc ctcaacaaag tattttagtt 180
agggttttac tgctgtgaaa agtcaccatg accccagcaa ctcgtttttg gttggttggt 240
tggtttggtt ggttggttgg ttggtttggt tggttggttg gttggtttgg ttggttggtt 300
ggttggttgg tttggttggt tggttggctg gttggtttgg ttggttggtt ggttggttgg 360
tttggttggt tggttgtttg gtcggttggt tggttggtta gtttggttgg ttggttagtt 420
tggttggttg gtttggttgg ttgtttggtt ggttggtttg gttggttgat ttggttggtt 480
ggttggttgg tttggttggt tggttggttggtttggttgg ttgattggtt ggttggtttg 540
gttggttggt tggttggttg gttgtttatt gctttcccag acaatggtcc cctccctggc 600
atctttgagg atttgcttta ctaggctgat cttcccagac caaaaccctc aggacgcagc 660
attaaagcgg cacacaccaa ttcacgtgac atctgctttc ctaaatcagc ctcacttcct 720
gtcaggattg cctccctaca ccgtgggcac atgcaaccct gagtgttagc aggccctacg 780
acaaaaacag agagagaaag gaaaccacaa aggaggcacc cggaacctgt gacctcagct 840
cccacaacaa acacctgaaa cactgcacca cgctttcaca ttagggttca gctcaccaga 900
aagaaatggg caaaagggtg gacatgtggc tcacttagta gattgttctc tcaaatagac 960
tcagtgctaa gggcgggggg ggggttattt ttgggttttt ttgagacagg atttctctgt 1020
gtagccctgg ctgttctctc tgtagaccag actggtgtca aagtcagaga tctgcctgcc 1080
tctgccttcc aaatgctggg attaaaggtg tgagccacct ctgcctgact gatgttaggt 1140
ttaacattta gcactgcata aactaggtgt ggtggtgcat ggctctcatc cttatcatac 1200
atatatacat acacacacat acacacacat atatatatga catatatatt atgtatatat 1260
catatatatg ataaagatga gggacatata tatatatgta tgtatatgaa tgataagaat 1320
gtatatgtgt gtgtgtgtgt atcactaaca tcagaaagga atgtcaagta ccatggctgg 1380
ggacagcact gaatccagag gcagctgcca aggcgctgtc agcaagcact gtccagagct 1440
tcgcttaccc agagtctgag aaagaaaacc gttagagcta ccagacagga cactggacaa 1500
taaatcctcc taaataaagt agaagcctta agggaatcta aacaaagagc cggaacctac 1560
tcaacaattc agaagctcag ccatttgtct gctccaaaaa atgtcttcccagagggcctc 1620
aaaacagcac ctgctgtagc cttgctcctg ctgtcaccac agtcagatgt gaagacccta 1680
ttgctgaaaa cgtaacacag tgtgggcagt gtggtcgcta gagagatagt tctgggttat 1740
atagaaagca ggttgagcaa gccagtaagt gctgtccccc tgtgatctct gcttcagttc 1800
ctgcctccag gttctgtaag tcagaagtct aaaggaggcc tcagccaggg atgcagctca 1860
cggcctggcc tcagccccca actcattgcc ctcatcttcc ttccgtcttg caaatcagca 1920
atgagtcctc atatgactgc ttgtttgttc ttctgcttcc acttgagacc acttaatatg 1980
cccagcagag ctgtgcacct ctttaatccc aagcattcag gtggcagagg caggtggatc 2040
tcagagtttg agaccagcat ggtctacaga tgtaaacaac accgagagac agggtcctcc 2100
tggctggcac aggcttcggc cttttctttc tcccagcatg agattcctgg ggaaattcca 2160
gtttcttggg ggaccatttt tgcagtcatt tctgtagcca aaggatatct tcattcctac 2220
cagggcagga gaataaaaac attcaaacac ataaaataaa caaacccttt gaaattattt 2280
taaaatattt tcaaaaacat atttctaata agagattagt atctgaaaca gtaactaaaa 2340
tcaagatgat tagaacagaa gcaaaagacc taataaacat ttcttcagag aagaggtaca 2400
attctcgata agcatgtgaa aggctaagga gaggagaatt gggatctcac ggtttagcag 2460
gtatggagtt tggggttata ttgcttgttc atgtatgagg gggagggcgt tggtctcact 2520
gcttctggcc aggatggtct cctggactta aatgacccct cccactcaag ctcccgagga 2580
ccaagaacct cagacaggca catgtcatca tgtccagctt aagagttcca attttatagt 2640
ataaagagaa tatacagatg aaaggtgatg cgttggctgt catggttaca gcgaaactac 2700
ttcagaagac aacttggaag gagaaaggag ttgacttcgg ttcacagtgt cagagatgtc 2760
aacctctgac tgactagtgc cattgcttct gggcctgtgg tgaagcagaa ctttatggtg 2820
aaaagggtgt ggcagagtcc tctcacttca cagcatctag aaagcagaga caccgaggga 2880
gacggagaga ggaaggaagg ccatgaggat aagacacacc attcaaaggc ttgattctag 2940
tgagccacta attctaactt ggccccactg cctatttagc catgtagtca tcaagggagt 3000
acttcgtgga tgaagcctgc ttacctcccc atggcactgc tgctccagcc atgagccctc 3060
tgcggtacac ttcatatcta ccttgttagg gtttccattg ctgtgaagag acaccatggc 3120
cagggcaact cttataaagg aaagcatttc attggggctg gcttacagtt tcagaggttt 3180
agtccattat catcatggca ggaagcatgg cagtgtgaag aaggcacggt gcgggaggag 3240
atgagagatc tacatcttga tcctaaggca gccaggagac tttcatccac actgggtaga 3300
gcctgagcat tggaggaaac cttaaagcca caactataca cttcttccag caaagccata 3360
ctctaaccag gccacacctc ctaaaaatgc cactccctgg gccaagcatt caagcacatg 3420
agtctatggg gcccaaatct attcaaacca ccacattagg caaacctaac accagtgtta 3480
cttcaggaga gccaggcagg ccctgtccct gtcctgagcc tgtggaggaa gatagacttt 3540
gaacctagag gtggaggctt tagatgagga cacaactcat ggtctggcca agatgttaag 3600
ttctctgtgc actcaaagcc tctttttagc aactttcttt ctacagttct tcaacgccag 3660
gtcctattca ttcctacagg gtcagccgtc agctccccgc acccatgaca tctgtcttca 3720
gatttatgac taacggtgaa gatgttggag cctgggaatg aggaaggaaa ttccttccgt 3780
tgtaaagttg tcgcggcctc tgctgggcat gtggtggagg gtggtttcct ttaaacagaa 3840
catgctgcag ctcctggctc gagtggaccc ttgaagagct gtagtggggg ctggggaaag 3900
ggaggagggt ggaaaaaatg aagagacagg aagctgaagc atgagataga aagaacagat 3960
ctaacatccc ccaggtgcga ccacagggct gtgacatttc accaacacta tggaaacaac 4020
tgtgaagccc ccaaatgaga catatccttg agataagtca gcaggggaaa gagtggaggg 4080
ggttcaatgg cccgtgcttc tccagtgtag caactccagc atcctcaaat cagaattccc 4140
agaggagcat gaggcttaag atgatggccc acgtaggtgc ccaccttcaa tcccatgtgc 4200
ccagggccat gaagagagat ggctcaggta cctgaagata ctagtgacca agccagccag 4260
aagcaggaag gataaaaatg ggattaggtc aagaaggaag tttggcaaaa gttcccccag 4320
gcagtgggtc acatctgtgt cacaggctgg cattaagaag aaataaaacc aggctggagt 4380
ggtagctcag tcaggaaagt acaagggcct gagtctgatc gccaaaaccc agtttttgag 4440
ttcatttctt tgtttgtttg ttttgctaaa ggatcccagg gtttgatggt catccagcct 4500
cctctactag gcaagttgca ggccagtgag aaataataat ctccatcttc tttatcatca 4560
ccaccaccat catcatcatc atcgatgtcc ctgaggaatg aaaccaaggt tgtcccctga 4620
cctccatacg catgaacacc tacacacaca cacacacaca cacacacaca cacacacaca 4680
cacacacaca catgtgcaca caaggattaa agggacttga tatcacagaa cagaaaaaga 4740
cacagggaac acagggctaa ctcttgccct caattgtatg caatgttcaa gagcttgtat 4800
agccagaaac tcaaacctca gttatataag gctggttgtc atgactcctc ccctttatac 4860
atgcaatagc tttgctgcgt gtgctgtgtc caagctggga atatagctca gacagcagtg 4920
tttgcctagg atgcaaaaag ccctgggttt catccccagt accacataaa cgggatgcgg 4980
cagcacagcg ctatggcacc agcagcagtg gcttggtagc aaaccctgca acaccaggaa 5040
cactcaggag agggaggcag aaagatcaga agtcccaagt catcctcagc taccaagcaa 5100
ccttgaggct accttggcat atataagacc gtcttccaaa ctgttgtgct tagccgtgtc 5160
accccacctc taatggggtg ttttgtggta ctagttttag gcaaaatctg aaaatgtcat 5220
gattttaaaa ctaacctgcc cctaggagct tcagaaataa tctgtaatct gctcctatct 5280
ggtcacctct ggaagggctg ggctatgaga gaggacactt gccagggaca gatgagggca 5340
cccagcgtcc atccctatca acaggtccgg cggctgtggg tattcattac tgagagaggt 5400
gcccaagggg ggcacatgtc tgtgaagctc agcagagctg ggtttacccc ttcatagtct 5460
ctccggagtg cggaaaagag aagggggtgg aggctgctga gagagagaca aagaaaacca 5520
aaacagccac aactgccttc aaaggtcggt ttaccaccca agtggagtcg cagtggctgc 5580
tgcccagagc acataggagc caccagtgac tcggtacaag cagttggggc tcagaaaaga 5640
tctccctggg caggagctat ggcacggcca catccctggt ggctgtgcgt tctggggacc 5700
ctggtggggc tctcagctac tccagccccc aagagctgcc cagagaggca ctactgggct 5760
cagggaaagc tgtgctgcca gatgtgtgag ccaggtaaga gggggccttg gtaagggcca 5820
ggtgagtggc gaaagagaga ggactggggt taatacagta aataggcgca gggtgagact 5880
gagctcaagc aaggagggaa atcctgcagc tgtggggagg caccaccttg aagagggcag 5940
agaaccagcc cttctcaggc cttgatccct taccctctcc tcccaggaac attcctcgtg 6000
aaggactgtg accagcatag aaaggctgct cagtgtgatc cttgcatacc gggggtctcc 6060
ttctctcctg accaccacac ccggccccac tgtgagagct gtcggcactg taactctggt 6120
gaggtgggca agggtgtgta ggtggggacg atggacaagc atctggggga gcaaggctgg 6180
tgacgggttt gggggtgcaa ggaggatgac ggggccaaag ctttggcctt cttcaaggct 6240
cacagcaagt ggagccaatg ctgggaaatg cggcacccta ggtggggcat gaattaacgt 6300
gggcagacat ctagtattcc aggaaaggga taaatagaat ttgagggatt ggtgagaacg 6360
ggtctatgga taggatcaag acaataaaat gagagaagtg gctctatgac cccagatttc 6420
gggcaagcaa cccccaacca ataaactgac tgtgttccca gagtgcacat gtgcaggttg 6480
gccattggga atttggaata catctttcta aggaaataac aaagcaaccc aataggtaac 6540
aacctttttt tgcacaaaag ccaatttgag aaaatgagta tgtatgtagc ctgtgttttt 6600
attttatagt tccaaaaaaa aaggtttttt ttaaactaag aagtataata tctgcagttg 6660
tgcttatgaa tgctgttatt atttctccat cttcgctaca atttcagaaa ctacggccag 6720
tatacactag aatagcaggc tttaaagtgg cccctttgaa caaatgttct ctagcaagac 6780
actttttaga accaggtaac tgtaactatt aaactaccta cttgcaaaac gtgtttggtg 6840
tcactgggtc tcttggtact gggttttgtt ttgtttagtt tagagacaag gtctagctct 6900
gtcacccagg ctggagtgca gtggtgcaat catagctccc cacagccttg aactcctggg 6960
ctcaagcaat cttctagtct cagcctctga aagtgccagg attacaggtg tgagctgtag 7020
tgcctggtcccgtaaaaaca aaaacaaaaa ccaacaccag atgtggtggc tcatgcctat 7080
aatcccagca cttgggaggc caaggcagaa gggtatttgc atattttgta gagacttgag 7140
cccaggagct tgagaccagc tgggcaacat agtgagacct tgtctctaaa aaaattggct 7200
ggtcatggta gtgcacctgc agtcccagct acttgggagg ctgagatggg aagatcactt 7260
gagcccaaga ggtccccaag aggtccaggc tgctcacatc actgcactcc agcctgggta 7320
acagagcaaa accctttttc acacacacac acacacacac acaaaaagcc agagcagtgg 7380
ctcacacttg taatcccagc actttaggag gccaaggcag gcggatccct tgagcccagg 7440
agtttaagaa caccctgggc aacatggcaa aaccctgtct ctactaaaaa tacaaaaagt 7500
tagccaggcg tggtggcacg aacctgtagt cccagctact cagaaggctg aagtgagaag 7560
atcacttgag tccaggaagt ggaggctgca gtgagccgtg actgtaccac tgcactccag 7620
cttgggagac agagtgagca gagtgagacc ctgtttccaa aaaaaaaaag aaaacaaaag 7680
cttttccatt gcaaatcaac caaaaaggaa cgtctttaat acacaagaaa tattcttcag 7740
tctacttaac ttaaaaatgt aactgtaata gatgcttttc tcttgacagc ggccccggca 7800
gggttggaac ttttcctagt caaaaccccc ctactcactc tgcagaccct tcctgaaggt 7860
cttcgcccca tactgagccc atcttcagtc ccttcacttg ttccaaacta gcccaatcca 7920
tgacccttct ctgggagctc agccaataga tcccaaagta ccacagcagc acctggctgc 7980
agaaggaccc ccgggaaatg cagtcagggg tgagaagatg ggtgggctga atgagctcgg 8040
ccctctctgg gccttagtgc tggcatctat gagatgagga catgcctgaa gtcagcctgg 8100
aattttgagc ccaggttaaa ggcgcataac gataccacga tatcaacaag tttgtacaaa 8160
aaagcaggct ggcgccggaa cgcatgcaga tctacgcgtg attaacttta aataattggc 8220
attatttaaa gttattaatt aaccccccca aaaaaaaggt gcctatcacc cttctgccta 8280
cctgtgtatc ctcaggacat ggtgggcctc tctggttggc agaaagcaca acaaagcctc 8340
ttcatcctat actacttctc ttgaccagat gccaagtcta atatgaactg caatcctcta 8400
tacaccaaaa gttcatgggg gcaccgtgag gtcccactcc acctcagcca attccttgtt 8460
gctgccccac tcacctcctg agcctccctc tgtttcctgt ccacctttca gcttccctct 8520
caggctggga gcaggggcca gtagcagcac ccacgtccac cttctgtcta gtaatgtcca 8580
acacctccct cagtccaaac actgctctgc atccatgtgg ctcccattta tacctgaagc 8640
acttgatggg gcctcaatgt tttactagag cccacccccc tgcaactctg agaccctctg 8700
gatttgtctg tcagtgcctc actggggcgt tggataattt cttaaaaggt caagttccct 8760
cagcagcatt ctctgagcag tctgaagatg tgtgcttttc acagttcaaa tccatgtggc 8820
tgtttcaccc acctgcctgg ccttgggtta tctatcagga cctagcctag aagcaggtgt 8880
gtggcactta acacctaagc tgagtgacta actgaacact caagtggatg ccatctttgt 8940
cacttcttga ctgtgacaca agcaactcct gatgccaaag ccctgcccac ccctctcatg 9000
cccatatttg gacatggtac aggtcctcac tggccatggt ctgtgaggtc ctggtcctct 9060
ttgacttcat aattcctagg ggccactagt atctataaga ggaagagggt gctggctccc 9120
aggccacagc ccacaaaatt ccacctgctc acaggttggc tggctcgacc caggtggtgt 9180
cccctgctct gagccagctc ccggccaagc cagcggcgcg ccgccaccat gggtgctagc 9240
gagctgatca tctctggctc ctctggagga ttcctgagga acatcggcaa ggagtaccag 9300
gaggctgctg agaacttcat gagattcatg aatgaccagg gagcctacgc ccctaacacc 9360
ctgagagacc tgaggctggt gttccactcc tgggctagat ggtgccacgc tagacagctg 9420
gcctggttcc ctatctctcc tgagatggct agggagtact tccttcagct gcacgatgct 9480
gacctggcct ctaccaccat cgacaagcac tacgccatgc tgaacatgct gctgtcccac 9540
tgtggcctgc ctcctctgtc tgatgacaag tctgtgagcc tggccatgag gagaatccgg 9600
agagaggctg ccaccgagaa gggagagaga accggccagg ccatccctct gagatgggat 9660
gacctgaagc tgctggatgt gctgctgtct agatctgaga gactggtgga cctgaggaat 9720
agggccttcc tgtttgtggc ctacaacacc ctgatgagga tgtctgagat ctctaggatc 9780
agagtgggag acctggacca gaccggagac accgtgaccc tgcacatctc ccacaccaag 9840
accatcacca ccgctgctgg cctggacaaa gtgctgtcta ggaggaccac cgctgtgctg 9900
aatgactggc tggatgtgtc tggcctgaga gagcaccctg acgctgtgct gttccctcct 9960
atccaccgga gcaacaaggc taggatcacc accacccctc tgaccgcccc tgccatggag 10020
aagattttta gcgatgcctg ggtgctgctg aacaagaggg atgccacccc taacaagggc 10080
cgctaccgga cctggaccgg ccactctgct agagtgggag ctgccatcga catggctgag 10140
aagcaagtgt ccatggtgga gatcatgcag gagggcacct ggaaaaagcc tgagacactg 10200
atgagatacc tgaggagggg aggagtgtct gtgggagcca actctaggct gatggactcc 10260
gctagcggcg ccggtcctaa gaagaagagg aaagtgtgag gccacgtagg cccgcgatga 10320
ataaatgaaa gcttgcagat ctgcgactct agaggatctg cgactctaga ggatcataat 10380
cagccatacc acatttgtag aggttttact tgctttaaaa aacctcccac acctccccct 10440
gaacctgaaa cataaaatga atgcaattgt tgttgttaac ttgtttattg cagcttataa 10500
tggttacaaa taaagcaata gcatcacaaa tttcacaaat aaagcatttt tttcactgca 10560
ttctagttgt ggtttgtcca aactcatcaa tgtatcttat catgtctgga tctgcgactc 10620
tagaggatca taatcagcca taccacattt gtagaggttt tacttgcttt aaaaaacctc 10680
ccacacctcc ccctgaacct gaaacataaa atgaatgcaa ttgttgttgt taacttgttt 10740
attgcagctt ataatggtta caaataaagc aatagcatca caaatttcac aaataaagca 10800
tttttttcac tgcattctag ttgtggtttg tccaaactca tcaatgtatc ttatcatgtc 10860
tggatctgcg actctagagg atcataatca gccataccac atttgtagag gttttacttg 10920
ctttaaaaaa cctcccacac ctccccctga acctgaaaca taaaatgaat gcaattgttg 10980
ttgttaactt gtttattgca gcttataatg gttacaaata aagcaatagc atcacaaatt 11040
tcacaaataa agcatttttt tcactgcatt ctagttgtgg tttgtccaaa ctcatcaatg 11100
tatcttatca tgtctggatc cccatcaagc tgatccggaa ccgcttggct gcaggtcgtc 11160
gaaattctac cgggtagggg aggcgctttt cccaaggcag tctggagcat gcgctttagc 11220
agccccgctg ggcacttggc gctacacaag tggcctctgg cctcgcacac attccacatc 11280
caccggtagg cgccaaccgg ctccgttctt tggtggcccc ttcgcgccac cttctactcc 11340
tcccctagtc aggaagttcc cccccgcccc gcagctcgcgtcgtgcagga cgtgacaaat 11400
ggaagtagca cgtctcacta gtctcgtgca gatggacagc accgctgagc aatggaagcg 11460
ggtaggcctt tggggcagcg gccaatagca gctttgctcc ttcgctttct gggctcagag 11520
gctgggaagg ggtgggtccg ggggcgggct caggggcggg ctcaggggcg gggcgggcgc 11580
ccgaaggtcc tccggaggcc cggcattctg cacgcttcaa aagcgcacgt ctgccgcgct 11640
gttctcctct tcctcatctc cgggcctttc gacctgcagc ctgttgacaa ttaatcatcg 11700
gcatagtata tcggcatagt ataatacgac aaggtgagga actaaaccat gggatcggcc 11760
attgaacaag atggattgca cgcaggttct ccggccgctt gggtggagag gctattcggc 11820
tatgactggg cacaacagac aatcggctgc tctgatgccg ccgtgttccg gctgtcagcg 11880
caggggcgcc cggttctttt tgtcaagacc gacctgtccg gtgccctgaa tgaactgcag 11940
gacgaggcag cgcggctatc gtggctggcc acgacgggcg ttccttgcgc agctgtgctc 12000
gacgttgtca ctgaagcggg aagggactgg ctgctattgg gcgaagtgcc ggggcaggat 12060
ctcctgtcat ctcaccttgc tcctgccgag aaagtatcca tcatggctga tgcaatgcgg 12120
cggctgcata cgcttgatcc ggctacctgc ccattcgacc accaagcgaa acatcgcatc 12180
gagcgagcac gtactcggat ggaagccggt cttgtcgatc aggatgatct ggacgaagag 12240
catcaggggc tcgcgccagc cgaactgttc gccaggctca aggcgcgcat gcccgacggc 12300
gaggatctcg tcgtgaccca tggcgatgcc tgcttgccga atatcatggt ggaaaatggc 12360
cgcttttctg gattcatcga ctgtggccgg ctgggtgtgg cggaccgcta tcaggacata 12420
gcgttggcta cccgtgatat tgctgaagag cttggcggcg aatgggctga ccgcttcctc 12480
gtgctttacg gtatcgccgc tcccgattcg cagcgcatcg ccttctatcg ccttcttgac 12540
gagttcttct gagcgggact ctggggttcg aaatgaccga ccaagcgacg cccaacctgc 12600
catcacgaga tttcgattcc accgccgcct tctatgaaag gttgggcttc ggaatcgttt 12660
tccgggacgc cggctggatg atcctccagc gcggggatct catgctggag ttcttcgccc 12720
accccccgga tctaagctct agataagtaa tgatcataat cagccatatc acatctgtag 12780
aggttttact tgctttaaaa aacctcccac acctccccct gaacctgaaa cataaaatga 12840
atgcaattgt tgttgttaac ttgtttattg cagcttataa tggttacaaa taaagcaata 12900
gcatcacaaa tttcacaaat aaagcatttt tttcactgca ttctagttgt ggtttgtcca 12960
aactcatcaa tgtatcttat catgtctgga tccgggcggc cgctaacttt aaataattgg 13020
cattatttaa agttacaccc agctttcttg tacaaagtgg ttgatatctc tatagtcgca 13080
gtaggcggta cctggtaaat agaactccca ggtctccgga tactcaccac taaaacaata 13140
gcacctcatt gtttttgttt tgttttgttt tgttttttaa ttatacttta agttctaggg 13200
tacatgtaca caatgtgcag gtttgttaca taggtataca tgtgccatgt tggtgtgctg 13260
cacccattaa ctcatcattt acattaggta tatctcctaa tgctatccct cctccctccc 13320
cacaccccac gacaggcccc agtgtgtgat gttccccttc ctgtgtccaa gtgttctcat 13380
tgttcaattc ccacctacga gtgagaacac attgttttta accctcccca gcagcttctt 13440
taacccctcc atttcccttt tggcggagac ccttgtcatc actcctctct accaccagtg 13500
ctctcccctc ctgcactgtc ccaggcttcc tcattcttcc cttgcaggtc cttatccaac 13560
atggctcaca attcctggga agccacaagg aaaccaaatt ctagtagcaa ctcagagtca 13620
gcattcatta gcaggtcaca gggccataag gatgccaaga aggaatttgt ccctctcctt 13680
gtcctgacaa aaggcataag tagaagaaaa ttgttaggtt tggttatgac ctttgacatt 13740
ctctctttga catcctccct ttctgcaccc ctcttccacc tgtcagggca cctagggctc 13800
cccgggtccc cacaagtgtc tgccctaagg cccaccaggc tttcttgcag cctgtcccac 13860
atctgggtgt cactgccttc ctctgaatca ccctcctctc aaaccagccg ccagcgagcc 13920
cagcccagcc cagctagtgc cctaccacac ccgcccccag gataattaac acccagccac 13980
ccagcatcgg acctctacac ttgagcaaaa tgtatatttt aaaggcaaat tctcacgcct 14040
gtaatcccag cactttggga ggccaaggcg ggcggatcac gaggtcagga gattgagacc 14100
atcctggcta acacggtgaa accccgtctc tactaaaaat acaaaaaatt agccaggtgt 14160
ggtggcacac acctgtaatc ccagctacta gggaggctga ggcaggagaa tcacttgaac 14220
tcaggaggcg gaggttgcac tgagccgaga tcgtgccact gcactccaac ctgggcgaca 14280
aagcaagact ctgtcaaaaa acaaacaaac aaaataaagg ctaagtaact gtaatcaagt 14340
aactatttat tatttattta ttttagtgta tccacaggtt gtgcagccat caacactatc 14400
taattctata acattttcgt taccccagag aaacttgtac cccttagcaa tgactcccca 14460
tttcttcccc ccaaccaacc ccagccccag ccccagcccc tgggaatccc taatatactt 14520
tgttttgttt tttgttggtg gtgtttgaga caggatctca ctctgtcacc caggctggag 14580
cgcagtatca tgatctcagc tcactgtaac ctccacctcc cgggctcaag cgatcctccc 14640
acctcagcct ccccagtagc ttgggcctac aggtgtgcac caccacaccc agctaatttt 14700
tgtatttttt gtagagacgg ggtttcacca tgttggccag gctggtctca aactcctgag 14760
ctcaagcaat ccacccacct caacctccca aagtgctggg attacaggcg taagccactg 14820
cacctggcta ttttctttct ttcttttctt tttttttttt ttttgagacg gagtttcact 14880
ctgttgccca ggctggagtg cagtggcgtg atctcggctc actgcaactt ccacctcccg 14940
ggttcaagca attccctgcc tcacccggct attttatatt tgttgatctg ctgctggtta 15000
tgcctgtgag ccaaatttgt acaaattctt aagctttaca atcatgcgtg cctctctgta 15060
cgtatattat actttaatta aaagttatta aagtattggg gccgagcaca gtggctcacg 15120
cctgtaatcc caacactttg ggaggctgag gctggtgcat cacctgaggt caggagttta 15180
ataccagcct ggccaataca gtaaaacccc gtctctacta aaaatacaaa aaattagccg 15240
ggtgtggtgg cacacacctg taatcccagc tacttgggag gctgaggcag gagaattgct 15300
tgaacccggg aggcagaggt tgcaacgagc caaggtcacg ccattgcact ccagcctcgg 15360
caacaagagc gagactccat ctcaaaaaaa taaataaaaa ataaaaaatg tatcagggag 15420
tacaagagaa agtcatataa gctctttcta cttttcatgg tttctatgtc tgaacccatg 15480
aatcttcctt ctgaaaggtc caactttctt ctttaataac aataataatg gcaaaggcat 15540
tgggggaccg tgagcaaagg gcaggccttt gcaggggtgg gaatggaaag ggaagcacgt 15600
ccctagaggt gggcctggga tgggggttgg gggatgaagc aagtggacct tgaaggtctc 15660
cacaggtctg agtgtcctat gctccctggg cctctcttcc cccaggtctt ctcgttcgca 15720
actgcaccat cactgccaat gctgagtgtg cctgtcgcaa tggctggcag tgcagggaca 15780
aggagtgcac cgagtgtgat cctcttccaa acccttcgct gaccgctcgg tcgtctcagg 15840
ccctgagccc acaccctcag cccacccact taccttatgt cagtggtaag ttccaggcaa 15900
ctctctgtgc catcacgtgg ggtagcggtg ataccccaac cagtactccc cactcctacc 15960
cctagataag gtcagcctgt ttctgccttc ccatcccatc cagcacctct caggccttca 16020
gatgtgccct atggggtccc ctgctgctac tcattctgtc tctgtttttc cagagatgct 16080
ggaggccagg acagctgggc acatgcagac tctggctgac ttcaggcagc tgcctgcccg 16140
gactctctct acccactggc cacgtgagtt ttctccttaa tccccaccgc tagagagaat 16200
gcatacacga ggggccagga gggaagccag acagaaagct cctaggatta gggataagag 16260
gaggggaaaa agcagagtcc actgtttagg agaggagttg gccaacggtg gcgggtggga 16320
tagaataagg tgggggaaag gggagaggca aggtgacagg agggctgggc tgagggagcc 16380
aagggctaga ccctccccta acccctgtgt gtcccctcct attacagccc aaagatccct 16440
gtgcagctcc gattttattc gcatctttgt gaccttctcc agcatgtttc ttatcttcgt 16500
cctgggtgca atcttgttct tccatcaaag aagaaaccac gggccaagta agacacaggc 16560
cttccctcct gtctctcagc tgtgctaccc acacctaaag cccccacacc tactccaccc 16620
acctactctg gctcctcaag tgtccttccc ccagactccc caagcccccc agctctcagc 16680
cctccacttg ggcttttctc ctcttttctc cccttcacct ttcttctctc cactgctgac 16740
cgattgtgtt tgcacagatg aagaccggca ggcagtgcct gaagagcctt gtccttacag 16800
ctgccccagg gaagaggagg gcagtgctat ccctatccag gaggactacc ggaaacccga 16860
gcctgctttc tacccttgac cgggtgctgg tggggccctt tctgacgagg ggccatccac 16920
agagacctca atggtggcct gctcccctgt catggtcatc agaacccttt cctgtgaata 16980
ctcaacaaac tgcccttctg agaccaacag ggacaagagc aggatcccag tgtgtggccc 17040
agcaagctgg ggagactcag gctctagcta taaagcacac ttactctaag tgaaaccgtc 17100
cagctgacaa aactacatgc caggggtgga aatggctcac caagggctcc agagggggct 17160
tggcagtgag gagcacgaag tgttcctcca gaggaccaga gtttgattcc cagcactgtc 17220
aaatggatcg aaaccagctg taactctact ttcagagggt ctgacacctt tgacctcctc 17280
tggcatctac aaacacagga cggacacaca cacacacaca cacacacaca cacacacaca 17340
cacgattaaa aataataatt ttttttaaaa aaatggaatg agccaccggc aggtgccctg 17400
gtaccagaag gactgactgc cgtgagagac actatctaca gacacacaga cttcctggcc 17460
ttggttctgt cttctctgta agttgtgaca gtgctgtggg aaagctgagg ctgagacttt 17520
ctctcagttg agctaaaact ataaataaat tcatttgtct acttctatac acattgtccc 17580
ttctctctgt gcaggcaaac actggaaccc ggagccaagc cttacggccc agggactcta 17640
gtaacaagcc agctatggac actctccatg tgctattccc cttcctacag aatgagggta 17700
ggggaacaag aggaggagga ggaagaagaa aaaaaagaag ggacagtgaa ctaggaagaa 17760
ggatagtgta aatgctaact tcaaatacgc acacctacaa ctgaaacaaa caaacaaaca 17820
atccctcagt gtggccctga gcttgtaatt caaggggtta agtggtgtga caagggcggg 17880
gcttggagta gagacagcag gagatcactg ctgtgcttgt tggctaccaa acaattccag 17940
gttcagaaag agaccctgtc tctgaagaat aaggtggggt aatagagcaa gacacccagt 18000
gccctcaccg agcctccaca cacaggcagg gctgggcata ctcacccaca caagtgtata 18060
caccgcatat acacaaatac aagttaaaag tgagacttca catagctgtc cagcctccta 18120
aaattccaat cctagaacta ggccacaccc catctcgtct gttcgatcac agatctgaac 18180
agggagttgt caccagggca gacccaaagg atttaacatg gactgaaagg aagaagggtc 18240
cagagtaccg gggaatctat cttctggctc caccccctct ccagccctct catagttggg 18300
gctgatggga aagctgatgt ggtgatacca ggttttgaaa tcacctgggg atttcttggg 18360
tgcggggtgg accttaggga gaacagaaag cagagctggc tgcagccatt actggcctcg 18420
ggcgggcggc cacagaggca gttgaagtga aagtgaaaga gaaacgataa gagaacggag 18480
accacaggtg ctaagtgagg gtgctcacag aaccccctct tcagccagag atcactagca 18540
ggggaactgt ggagaaggca gccagcaagg aagagcctga gagtagcctc catgggcttg 18600
gagcccagct ggtatctgct gctctgtttg gctgtctctg gggcagcagg gactggtgag 18660
tgcggagacc aggctggggc ctgggggact gggggggagg aagcgccaag ctaaaggagc 18720
cccaggaagc caccttctca gaacagcacc agcttgtctg ctaagcccag caaatgagtg 18780
cggcactcac aacatgcgga accagtttgg agaggggtac ggcagagaac tcacagaaaa 18840
ggggggcttc ctcgatggga aggcagggtg ttagcattct gtgggacagc tcactgccct 18900
gagttgaatc cttagaagag gaaggggctc cccaggctaa gaaatcattg ggttggtgac 18960
tcctggtggg cgtggctatg gcagaaagca gaggcctctg ggaaagttgg gtgatgagaa 19020
aaaggttgtc aatgtcccta ggaacagcag tgtcttggct cctctcccct gtggcagtat 19080
ttcttattcc tttttttttt tttttttttt aacctgagaa ttcctttcca gaaattccct 19140
tgcatcccac agctgagact cagaaataca aagcataaac ccctctggct ttgatcagga 19200
cagatctagg acttgaaata actcacagag ccgctgcctg agtagcaggt gcctcagcag 19260
aagctgggtt tatagatgac accaggacag cggggctcag aaggcacctt tacctgctgc 19320
tcagcccggg gcttggtgaa ggggtgggaa gagtgtggag gacgagggtg cttgttccac 19380
tttccctgca gaccctccca cagcgcccac cacagcagaa agacagcggc agcccacgga 19440
catcatctta gactgcttct tggtgacaga agacaggcac cgcggggctt ttgccagcag 19500
tggggacagg gagagggcct tgcttgtgct gaagcaggta ccagtgctgg atgatggctc 19560
cctggaaggc atcacagatt tccaggggag cactgagacc aaacaggatt cacctgttat 19620
ctttgaggcc tcaggtaaaa tctccccatc ctaggcttcc tccacaggaa cagccccgtt 19680
cccagttcta tctacccacg cctgcccccc cccccccccg gtctggcgtt gtccatccaa 19740
cattacttct gtatgctgcc cttctcccca gtggacttgg tacagattcc ccaggcagag 19800
gcgttgctcc atgctgactg cagcgggaag gcagtgacct gcgagatctc caagtatttc 19860
ctccaggcca gacaagaggc cacttttgag aaagcacatt ggttcatcag caacatgcag 19920
gtttctagag gtggccccag tgtctccatg gtgatgaaga ctctaagaga tgctgaagtt 19980
ggagctgtccggcaccctac actgaaccta cctctgagtg cccagggcac agtgaagact 20040
caaggtgaga aaacaaaatg cagtggcaca ggaacatttt gtattattgt gtgtgtgtgt 20100
gtgtgtgcgc gtccatgcgc acatacgtgt gcacatgcca cagcacatag gtagagatca 20160
gaggacagct tatagaacct accatgtggt ttccagggat tgaactagtt cactatgctt 20220
ggcagcaagc actttatgca ctatgccatc tcaatagccc caagatagtt ttttggtttt 20280
ttggttttgg tttttttttt tttttggggg gggggttgtt gtttttttaa tttgtttttt 20340
gtttgtttgg ttggtttgtt ggttggtatt ttgttttctt ttgtggttag agatgggata 20400
gaaggaagaa aacaaatatc ccacaggtcc tcctgaggta cccatagagc ttcatctttt 20460
ctttctaaaa tatcctgagt caagaagagg ggatgctagg agatccttat tcgagcaagc 20520
atcaaaacat aataatcatc aggtattttc tccaaagtgg ggaagcaaca catgaggaca 20580
ctgtagctac acatgtcact acactcttat ttagccaaac tcatgtttcc tcccagggag 20640
agggagtctg gtctggtgct tcatggcaat tacagcagag cacagggaga aagaagtgct 20700
cagtagctct tactagtgag cccattcctc attctctccc acttagtacc tcctaccagg 20760
ttcaaaacca agaggaaaca tattgacagg cacctggaga gtccagttca ttattttgcc 20820
tccaaaaagg agaaaatcaa gtccacagaa gatgacgatg agggggcccc tctcctatcc 20880
ctgcaaaccc ctaaaacatt agcctttagt attatgttgt cccatactga ggatagaacc 20940
tagagccttg tgctaaacac gagctctact actaaactac agcttcaatt cctttttcag 21000
ttttattgtg aaacaggggt ctcacccaga tgccctggca ggcctggaaa cttgtgattc 21060
tgtcatgcct ccttagtagc tgatggtaca ggcatatact accacaccct ccggctctac 21120
agtcctttct gaatgtgcct tgccacatca gaaaagatgt tcagcatctc ctatccttgg 21180
ccatgggtag tttagtgctt ctcccttttt gaacttattc agatctacaa ataaatgaaa 21240
caacataccc ccacccagcc gtgacttatt tctgacctat ttcgtcagct gtcatagttc 21300
ctctctaccc gactaacata gatatcctcc cctggactga ctaggctgta gggaccacaa 21360
cacttcaccc ccaaatgctc ccatgtgcag ttagggctga tagctgaaag tcaaggccac 21420
tctgcttcac aataaccaag gatcccaaaa gcctatcaag gctggggagt gctctactca 21480
cagtaacaag ggtccagtgc acacaggact taacagtatt tcattcatgg aaagacgtga 21540
ctattgaagc tggacgtact gtccacatct gcagtccttg cacttggagg gactgaacca 21600
cgaagattgt gggtttaggc tctcatgtgt gccttgctgc accattaatt tatggctcca 21660
ctggacagga aatgaactca gtaccactgt ccagggaagg gagccggagc tgtctgtcca 21720
tggctcagag gccaggtgac cttaaggaag aaacagtctg taagtcaccc tttctttctc 21780
tctacagtgg agttccaggt gacatcagag acccaaaccc tgaaccacct gctggggtcc 21840
tctgtctccc tgcactgcag tttc 21864
<210>23
<211>24
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>23
gcagactcaa gtaccagtga aggg 24
<210>24
<211>23
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>24
tagtgcctct ctgggcagct ctt 23
<210>25
<211>23
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>25
cctattacag cccaaagatc cct 23
<210>26
<211>21
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>26
agcactcccc agccttgata g 21
<210>27
<211>22
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>27
catgaggtag ctggtaggac ct 22
<210>28
<211>23
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>28
ctttgttgag gggctcagag gat 23
<210>29
<211>21
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>29
ccaaatgctc ccatgtgcag t 21
<210>30
<211>23
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>30
acctggaact ccactgtaga gag 23
<210>31
<211>22
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>31
tcttatcatg tctggatccg gg 22
<210>32
<211>25
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>32
tgtcaaagag agaatgtcaa aggtc 25
<210>33
<211>23
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>33
cagtgactcg gtacaagcag ttg 23
<210>34
<211>23
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>34
gtcacagtccttcacgagga atg 23
<210>35
<211>22
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>35
gaagatgggt gggctgaatg ag 22
<210>36
<211>23
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>36
gggacaaatt ccttcttggc atc 23
<210>37
<211>22
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>37
aactgcacag tcactgccaa tg 22
<210>38
<211>24
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>38
gaaacagaca gagcgagtca caag 24
<210>39
<211>16
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>39
caagugugua agacga 16
<210>40
<211>17
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>40
ucuggucagu cagcgug 17
<210>41
<211>22
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>41
ggacacagaa agatgccttg tt 22
<210>42
<211>21
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>42
actaaggact tcccctgggc t 21
<210>43
<211>20
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>43
caggaggttc ccctaccttt 20
<210>44
<211>20
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>44
cttggttccc catctccaac 20
<210>45
<211>15858
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>45
gtgaggaccc tatccatgtg tgtaatatct caagttctgt gtgtctccat tgctcagtga 60
aggaagaatg tgggcacacg tccggtagat aagggggtgc tgtatcatgc caggggcaca 120
tggtaacatg aagcttacct gaagctacat ggatgggatg gtttagccca gaatccctgc 180
agaggctggc ccttttcctg ggctatccaa gggccctcaa cattgctgct ccttcagggg 240
acccatctca gtcacctgta ctgcctgact tgggctagac ccttccggtt ccagaatcac 300
tggctctaga gactcacatg catgtccctg tacggacatc tcgatataaa caagcatggg 360
tgtccaccaa cctaaaaatg taggggaatc caagcttccg aaggcctgga atgtgtccgc 420
catcactttg tgctgaggca gctgggaccg tcttcctttc gctgcattgc actgcactgt 480
tgctcaatgg atctccaggt tccctgcagc tctgctcagt agctgccttc ccagggcatg 540
gctaccttcc tcctctctgc ttgccagccc agatccatcc ctacccatcc ctgcccacgc 600
cacaagaaag agatgacaac tctgtttgta gaacaaagaa cactggagtc aggggtggga 660
actttgaaca tttcacatca cgggaccatt cataaaaggc tgttctgcaa cctcggtggc 720
cccacaatgg ggtctgagct ggatcatgag atgcttgact cctctgcagg gcatatgaga 780
cagctttctc tcctggttct gaaatggact cctggcatca tgcagagtga catggaccgg 840
gaaactgcct atggcttctt catgctgggt agcctgtaca taatgtaggg tcgagcctcg 900
tgtgtagact gctggggacc caggcaactg tggcttgcag gtcctgctgc tggtatgagg 960
gcagtgttgg cttccagctt gttctgggct tgtgctatag gcctctacat ggaccagtta 1020
aaactggact ggacatggaa ttggtgcctg aggcagccag tacagaaggc cctaatgaag 1080
caaggctgtc aggactggct ggggctgaag actgggacat taaaacctga cccttcagaa 1140
agaaaaagaa acattctgca aggtttcctt ggatttaaaa gtcatcatga gggctgagag 1200
ctttaggagc cttcctggaa ctgggtgatg ctcccagagg cagcagcctc acactgaaag 1260
gtagctagct aggagctagc ttagttaagg gatcctataa gaagagttgt gctgagggag 1320
agttgaagaa aagtaggaaa ttcccaaaat tgagcttctt ggaagctagt tgggaatagt 1380
actcctgccc cttggcaact agcatctcct accccgcccc tccccatggg aggcagcagc 1440
ctctcacccc atgagagttg gtacacagtc actctgttgt cacaacaact gtcatttaag 1500
caaataatct aggtgcttgc gaatggttcc ctctagcaca ggaactcata cctgcttcct 1560
aagactgtga tcatgaccca aggatccgtc gttacaagat ggttaaagag gaatttagac 1620
acagtgcacc ccagggaata ggggtggctg tttctgtgtc ctttgctgaa ctcattgtgc 1680
tgctaagtat gcaaagatgg cagtaagcag aagggctgcg cgctgccggt cccttctctc 1740
tgtgattgag gtctagccaa cctcaagaag ctatagccat gtttactttc aaacgctacc 1800
tcagagtttc caagctatgt gacagccaca gcccaaacat tctcagggca ggcccgggca 1860
gtgtctgggt ggggtctggg agtcacagga ggggcccaga gccaagcgga gcctgaggtg 1920
gagggaggga gggctgggtg gggctggacc tgtgtacaca accacaccta ctatcgggga 1980
gtagctgtgt ccagtcactg agcagaggcc aactagtgtt tcttcatctc cctgggaaaa 2040
gcagcagaca ggatggcctg gtggaaagcc tgggtaagtt gaaatggtct ggggagatgg 2100
gtccctagtc cttgttggga gtgtggagga cacaaaaagt aaagctgaac ctgcgaggcc 2160
aagtcccggt gaggaaactg ggagaaaaac cctgtccacg cttagaaaag ttaaggtttg 2220
aaaggtaaga cagttaaaaa taaaacaaga acattttttt ttttaatttt taactgcaaa 2280
gagaaagcta aaggattcga gtgtccagag ggagacttct gtaggggaaa agctacttta 2340
gtgcctctgt ggatatgtgc aatgtgtgag tttgtgcttg gagagactct agcaggctgc 2400
tccttgcaga agtagcagtg tgtgaaaggc gctagggggc ccaggaagtt gactttggaa 2460
aacattgccc tgtttgagca tttgaatgtt cagatgggtt ggatctaggt ctggagagga 2520
tcccggatgg aaggaacatc gagggacttg aatgacaggc taaggggttg gagctcgact 2580
tccaaacagt acggagccac ctctacccac atgtacagcc gaaacacctc atgggcaggc 2640
acacggctac atgtgctatg caccttcctc gtcccagctg gggcactcaa agagggaaaa 2700
gctgaggttc tgggacacca ggtagcttgc tcaggtccct cggacagctt agactagaga 2760
aagcccaaag tctctgcaca gtctccgggc tccttatagg cagaagatcc aagttggccc 2820
agcttcagga aaatctttgt tgctgtgcca ccacccagag agaagctgta ggtgtagatg 2880
ccccgggaag gggggggggg cgtctctgga cagataggac agactagaag gcaggaagag 2940
atgagctatc atcctgaccc tcaggagaaa gcagcccgag cagtggctgt gcatagcttc 3000
acagcagctg ctggcaatac gccttgtgca ggtgcacaca gcagggctct gagtgttggg 3060
cagttcctgc agtcagatgc tggccaaaat agcctgattc taggccctgc actccatagg 3120
gcaggggcag gggccatcct cttggggacc tgattggatt ggttggtact ctcagaacct 3180
tctgtatgga tggggacact cctgtcggca tctctcacca ctgtcactgg aacctcacag 3240
caagtctgta ggatgggtgg ctttacacac aagggtggaa atggagactc cagtaccaca 3300
gctgccacac tagtaagggt ttaggtctgg gcagcctggg tccggatgca ctcagtcatc 3360
cagcatctct gacccttggg agagcagact cagggcagca aggcttctgt atctgtccag 3420
gctgccagtg aggaccaaat gtcccctgag tacaaagttg gattaaatac aggactggag 3480
aggtcaaaag agtgacagag agtgcctgtc ttcaaaacag gttccccctt tgtggtgaag 3540
agatcagaca aaagtatgcc agatcctgca tgcccatgac agacggtgtt ctagacatag 3600
catccaaaat tgcctgaatt gcctttttcc tgggtgtgtg atggtctgga atcactggcc 3660
tcagggtagc tccatcagaa gcctgaggct gacatggaag ctgggataga tgcctcctaa 3720
tctccactct aggcagtgtc ccatccttgg cacccagaac gctgatctct ttctatagaa 3780
ccttagcaag ggaagagaga caggcttctc aatgtggtga tatctgagcc acccctggag 3840
ctgctgacaa atacaggtcc cagaatggta tgggggacac tcctcaatga ctaagtttct 3900
gacacttctt tgggtcaggc agagaaacta ggaagtgaga acttaaatgc tgcccacccc 3960
acacccctca gaaaacccac atgtctatgg gtgaggctct ctgcagtgaa acattccaat 4020
aaaacccagt gtctggaaaa gtgtgaatca tctgaagagt gggggaggta gacagagctc 4080
aggttgtgaa ccaggctgtg ggtgaagtgc cagcttacta gccaagccac caagcccagg 4140
ctcctaatac gactgctgga gaaggtggca ggctgagcaa catgcttaac gcactttaca 4200
gagaatgctc aagtagactt ctagtagtag cagtgtgtga cctcagaagc aaggagtgtg 4260
tgtgtgtgtg tgtgtgtgtg tgtgtgtgtg tggcagcatt tggctcactg gagaaacttt 4320
ccctaggaat tatttctaac agttcctgtt ataaagcatg gtgcaataaa tgggaaggga 4380
aactctattt ttggacacgt gaaaatcaac caaaggacac agaaagatgc cttgttcctt 4440
tctcagaagc aggaccctta tggaggtggg gacctgttgt gtatttccag ggtctagcct 4500
gaggcttgag gggacagaca atgagtgtag ggagaaaagg aaagataggt ggagggtgct 4560
tgagaagaaa ctaagagaaa aggaggcaaa cgggggagga gaggagacgg aaagaaggaa 4620
gccggacgaa ggggaagggc aggcaggtgg gtgtaaggac cctgcagcct gggtagagaa 4680
ttggtgaatg gttgggcgaa cgtgtgaggt ggaaagcagg tgggtggatg gggaacaaca 4740
gaagagctgt gtgagcaggt gggtgaacga ccagaggggt tcgactaaac tctccatctg 4800
aaggaaccag gtctcccctc aaccctaccc ctagttcccc ccactcttca ccacccctcc 4860
ccctaaaaca cacagggtcc tgcatcctaa gcatctgata aattatgcgg agcacacaga 4920
taagtggcct ttacactggc cccgcctact gcgactatag agatatcaac cactttgtac 4980
aagaaagctg ggtgtcgaca agcttgatat aacttcgtat agcatacatt atacgaagtt 5040
attaacttta aataatgcca attatttaaa gttactcgac gcggtacccc cggatccaga 5100
catgataaga tacattgatg agtttggaca aaccacaact agaatgcagt gaaaaaaatg 5160
ctttatttgt gaaatttgtg atgctattgc tttatttgta accattataa gctgcaataa 5220
acaagttaac aacaacaatt gcattcattt tatgtttcag gttcaggggg aggtgtggga 5280
ggttttttaa agcaagtaaa acctctacag atgtgatatg gctgattatg atcattactt 5340
atctagagct tagatccggg gggtgggcga agaactccag catgagatcc ccgcgctgga 5400
ggatcatcca gccggcgtcc cggaaaacga ttccgaagcc caacctttca tagaaggcgg 5460
cggtggaatc gaaatctcgt gatggcaggt tgggcgtcgc ttggtcggtc atttcgaacc 5520
ccagagtccc gctcagaaga actcgtcaag aaggcgatag aaggcgatgc gctgcgaatc 5580
gggagcggcg ataccgtaaa gcacgaggaa gcggtcagcc cattcgccgc caagctcttc 5640
agcaatatca cgggtagcca acgctatgtc ctgatagcgg tccgccacac ccagccggcc 5700
acagtcgatg aatccagaaa agcggccatt ttccaccatg atattcggca agcaggcatc 5760
gccatgggtc acgacgagat cctcgccgtc gggcatgcgc gccttgagcc tggcgaacag 5820
ttcggctggc gcgagcccct gatgctcttc gtccagatca tcctgatcga caagaccggc 5880
ttccatccga gtacgtgctc gctcgatgcg atgtttcgct tggtggtcga atgggcaggt 5940
agccggatca agcgtatgca gccgccgcat tgcatcagcc atgatggata ctttctcggc 6000
aggagcaagg tgagatgaca ggagatcctg ccccggcact tcgcccaata gcagccagtc 6060
ccttcccgct tcagtgacaa cgtcgagcac agctgcgcaa ggaacgcccg tcgtggccag 6120
ccacgatagc cgcgctgcct cgtcctgcag ttcattcagg gcaccggaca ggtcggtctt 6180
gacaaaaaga accgggcgcc cctgcgctga cagccggaac acggcggcat cagagcagcc 6240
gattgtctgt tgtgcccagt catagccgaa tagcctctcc acccaagcgg ccggagaacc 6300
tgcgtgcaat ccatcttgtt caatggccga tcccatggtt tagttcctca ccttgtcgta 6360
ttatactatg ccgatatact atgccgatga ttaattgtca acaggctgca ggtcgaaagg 6420
cccggagatg aggaagagga gaacagcgcg gcagacgtgc gcttttgaag cgtgcagaat 6480
gccgggcctc cggaggacct tcgggcgccc gccccgcccc tgagcccgcc cctgagcccg 6540
cccccggacc caccccttcc cagcctctga gcccagaaag cgaaggagca aagctgctat 6600
tggccgctgc cccaaaggcc tacccgcttc cattgctcag cggtgctgtc catctgcacg 6660
agactagtga gacgtgctac ttccatttgt cacgtcctgc acgacgcgag ctgcggggcg 6720
ggggggaact tcctgactag gggaggagta gaaggtggcg cgaaggggcc accaaagaac 6780
ggagccggtt ggcgcctacc ggtggatgtg gaatgtgtgc gaggccagag gccacttgtg 6840
tagcgccaag tgcccagcgg ggctgctaaa gcgcatgctc cagactgcct tgggaaaagc 6900
gcctccccta cccggtagaa tttcgacgac ctgcagccaa gcggttccgg atcagcttga 6960
tggggatcca gacatgataa gatacattga tgagtttgga caaaccacaa ctagaatgca 7020
gtgaaaaaaa tgctttattt gtgaaatttg tgatgctatt gctttatttg taaccattat 7080
aagctgcaat aaacaagtta acaacaacaa ttgcattcat tttatgtttc aggttcaggg 7140
ggaggtgtgg gaggtttttt aaagcaagta aaacctctac aaatgtggta tggctgatta 7200
tgatcctcta gagtcgcaga tccagacatg ataagataca ttgatgagtt tggacaaacc 7260
acaactagaa tgcagtgaaa aaaatgcttt atttgtgaaa tttgtgatgc tattgcttta 7320
tttgtaacca ttataagctg caataaacaa gttaacaaca acaattgcat tcattttatg 7380
tttcaggttc agggggaggt gtgggaggtt ttttaaagca agtaaaacct ctacaaatgt 7440
ggtatggctg attatgatcc tctagagtcg cagatccaga catgataaga tacattgatg 7500
agtttggaca aaccacaact agaatgcagt gaaaaaaatg ctttatttgt gaaatttgtg 7560
atgctattgc tttatttgta accattataa gctgcaataa acaagttaac aacaacaatt 7620
gcattcattt tatgtttcag gttcaggggg aggtgtggga ggttttttaa agcaagtaaa 7680
acctctacaa atgtggtatg gctgattatg atcctctaga gtcgcagatc ctctagagtc 7740
gcagatctgc aagctttcat ttattcatcg cgggcctacg tggcctcaca ctttcctctt 7800
cttcttagga ccggcgccgc tagcggagtc catcagccta gagttggctc ccacagacac 7860
tcctcccctc ctcaggtatc tcatcagtgt ctcaggcttt ttccaggtgc cctcctgcat 7920
gatctccacc atggacactt gcttctcagc catgtcgatg gcagctccca ctctagcaga 7980
gtggccggtc caggtccggt agcggccctt gttaggggtg gcatccctct tgttcagcag 8040
cacccaggca tcgctaaaaa tcttctccat ggcaggggcg gtcagagggg tggtggtgat 8100
cctagccttg ttgctccggt ggataggagg gaacagcaca gcgtcagggt gctctctcag 8160
gccagacaca tccagccagt cattcagcac agcggtggtc ctcctagaca gcactttgtc 8220
caggccagca gcggtggtga tggtcttggt gtgggagatg tgcagggtca cggtgtctcc 8280
ggtctggtcc aggtctccca ctctgatcct agagatctca gacatcctca tcagggtgtt 8340
gtaggccaca aacaggaagg ccctattcct caggtccacc agtctctcag atctagacag 8400
cagcacatcc agcagcttca ggtcatccca tctcagaggg atggcctggc cggttctctc 8460
tcccttctcg gtggcagcct ctctccggat tctcctcatg gccaggctca cagacttgtc 8520
atcagacaga ggaggcaggc cacagtggga cagcagcatg ttcagcatgg cgtagtgctt 8580
gtcgatggtg gtagaggcca ggtcagcatc gtgcagctga aggaagtact ccctagccat 8640
ctcaggagag atagggaacc aggccagctg tctagcgtgg caccatctag cccaggagtg 8700
gaacaccagc ctcaggtctc tcagggtgtt aggggcgtag gctccctggt cattcatgaa 8760
tctcatgaag ttctcagcag cctcctggta ctccttgccg atgttcctca ggaatcctcc 8820
agaggagcca gagatgatca gctcgctagc acccatggtg gcggcgcgcc gctggcttgg 8880
ccgggagctg gctcagagca ggggacacca cctgggtcga gccagccaac ctgtgagcag 8940
gtggaatttt gtgggctgtg gcctgggagc cagcaccctc ttcctcttat agatactagt 9000
ggcccctagg aattatgaag tcaaagagga ccaggacctc acagaccatg gccagtgagg 9060
acctgtacca tgtccaaata tgggcatgag aggggtgggc agggctttgg catcaggagt 9120
tgcttgtgtc acagtcaaga agtgacaaag atggcatcca cttgagtgtt cagttagtca 9180
ctcagcttag gtgttaagtg ccacacacct gcttctaggc taggtcctga tagataaccc 9240
aaggccaggc aggtgggtga aacagccaca tggatttgaa ctgtgaaaag cacacatctt 9300
cagactgctc agagaatgct gctgagggaa cttgaccttt taagaaatta tccaacgccc 9360
cagtgaggca ctgacagaca aatccagagg gtctcagagt tgcagggggg tgggctctag 9420
taaaacattg aggccccatc aagtgcttca ggtataaatg ggagccacat ggatgcagag 9480
cagtgtttgg actgagggag gtgttggaca ttactagaca gaaggtggac gtgggtgctg 9540
ctactggccc ctgctcccag cctgagaggg aagctgaaag gtggacagga aacagaggga 9600
ggctcaggag gtgagtgggg cagcaacaag gaattggctg aggtggagtg ggacctcacg 9660
gtgcccccat gaacttttgg tgtatagagg attgcagttc atattagact tggcatctgg 9720
tcaagagaag tagtatagga tgaagaggct ttgttgtgct ttctgccaac cagagaggcc 9780
caccatgtcc tgaggataca caggtaggca gaagggtgat aggcaccttt tttttggggg 9840
ggttaattaa taactttaaa taatgccaat tatttaaagt taatcacgcg tagatctgca 9900
tgcgttccgg cgccagcctg cttttttgta caaacttgtt gatatcgtgg tatcgttatg 9960
cgccttaata ttctggattg caagtgtgta agacgagggt ctgggtactt tggttatcaa 10020
gtttattcca taatccatag aatatccatc ctacagttct ctctaaactt aaccctctgc 10080
ccaatacgat cccatggtct tgcaaaccac ctgagctttg gggatgctca gcgtgtctcc 10140
tggccctctg aaatagccac acctcaccac aggaaagacc agaataggct tagaaccttc 10200
ctcacaagaa aaaaaaaatg tccagatgcc acatccagac acaaagccac tccttgtgag 10260
tttatttcca cccattctgc tgtacacggt gcggatgaga actgtgtgtg accagtccgc 10320
tatctgccct cagccaacag gtaatttctt tttataagct ctggtcccag ctgcaccagt 10380
ctattagttg gagcacccag tcacaccctg caaggctcca tctggtctca gagcccaggg 10440
gaagtcctta gtttaacaaa gtagactaca tggtaagcca ggaggttccc ctacctttcc 10500
tgtattttcc atcatgagca gacctgtttg tcttgcaggt tgaacaggag ggcgtcagcg 10560
tgaagggtag ttctcatttc aacccagacc ctgatgcaga gaccctctac aaagccatga 10620
aggggattgg tgagttacca cccatggcct ggccgctggg gcctcacatc ccacatcctc 10680
agaaagtgga tgccagggac agtcaggcat agacggggcc cccattttac taagtgactt 10740
agttacttac agcatcacac cggctctgag ttgagtggct gttccttccc aagtgacaat 10800
gacagggaag gccatcatta atctgaagtt tctcacttgt aaaacggctg ccaggactct 10860
ggactcgata gttctcttct gcttcataaa cacacacttc ccaatccatc aggggaagat 10920
ggattggcac caggcccact gtgggcatgg gatgggagtt taggtgtggc actgaggcca 10980
gggcgatcag ccacatggat cctgcagctt gtcctctacc ccacgctgac tgaccagaca 11040
gtcagctgct tcccgctcta gaactagtgg atcccctcga gggacctaat aacttcgtat 11100
agcatacatt atacgaagtt atattaaggg ttattgaata tgatcggaat tgggctgccc 11160
atacctcaca tgagcgtgag tgggaaggga ccggtttacc ctaggatttg gtctcgctcc 11220
aggtaggagt catctctcag ctggctctgc ccagtgagtc aggacactaa agagaactgc 11280
cgtgcccaaa ggggcctaga ctgcatcctc atacccactg tttccatgaa aactttactg 11340
ttatccccac ttctaatata agcaaatgca ggctccagga aatgagcctt ctcgtccatg 11400
acatacaagg cagactctca gacccaatgg tctagaattc gctgtgatat tcctctaatg 11460
tgaccaacac aagggaaaga cttaaaatat ctcccttggg catgcttcaa aggtccacag 11520
ttgttgtcca aagctccctg cccttggttg ctatgctatg aagtcaagcc tgagccatac 11580
ccaacactat gtaagttgga gatggggaac caagaggtgc actacctgga tgccttgttt 11640
acaccatgga aattggacgt ttgcagctcg ccccccttca gtcttttctg atgccccccc 11700
ccagaggtag aagggattct catactgtac actcctacag gaaccaatga gcaggccatc 11760
atagacgtgc tcaccaagag gagcaatgtg cagaggcagc agattgccaa gtccttcaag 11820
gctcaatttg gaaaggtaag caggttgggt gccaaagacc aggcagttcc tcccagaatg 11880
gaaatgtgta catagggcat attgcattaa aacaatactt ccattcatct gtggtcaagt 11940
ttctctggct gttctggttt tttgtttgtt tgtttgtttg tttgcttttt tggttttttg 12000
gttttttggt ttttttttgt ttttttgttt ttttttctgc aagagccatt tatagctccc 12060
aagccccagc atgacattag ccttgcatgg tctagcccca tttcttccct gttctctctc 12120
cagctttgct gtcccactac ctgaactgac cttccatatc cctgctccct ggcaacacct 12180
ggctcccttc tgtttcacag cacaggcaca tgcttctcac aggggagtta cttgtgtgtt 12240
cctctcctgc ctgtggatac tctaggggca ctttggctgc tcccagccct tagcacagaa 12300
ccagaggcgc acagtgaatg ccagaggttt gtgcataggc atgtgggtgc ctagagtctc 12360
cccatttgct cacagattta acacaaaagc atcagtgatg aagtttagtg aagccatatg 12420
taactccttt cccctccaag ctacacatta tcctccgagt tcaacatcag aaaggttgag 12480
taatttccta aggctccaga gctcttaagt gacagtctga cagccctgta caaatcagct 12540
gggtgtgacc tagtggcttc ttgtagttgt gtgtgccctc aggaagagtc aggttgagac 12600
agaatcttgg aatctctttc tttctttccc ttcctcctct ctctccaacc ccctctttcc 12660
ctctcctcac tgaatcatgt aataagttaa gcatggagct gccaccctcc gatcttgcag 12720
tcccgaaagc aatggcaatc ctattttcct gagtttagaa tgtgcccagt actggactgt 12780
gtgctgagct gtcacatgtc tgtgtcatca caccaacagg acagagtcca tgtgggaagg 12840
aagaaagagt ccccaggcca gccttaacca cctgcctgca ctgcagtggg cttagaagat 12900
aagtcatctc gacctttctt tctgcctgtc ttaggacctc actgagacct taaagtcaga 12960
gctgagtggc aaatttgaga gactcatcgt ggccctcatg tacccgccat acagctacga 13020
ggccaaggag ctgcacgatg ccatgaaggt actccacttt gccataaatc agagtggcca 13080
cctgggcctg actgacctaa tgagcttgca acctgctcca acagccgccc agcagtgggg 13140
ctgaccagtc acaataaagg tctagatcag tacttcttag aatagggttg gaccagcagg 13200
agtgcagggg aatcggaaat ccatctctgc agtctgagca ctgccccttg gccatccttt 13260
gcttcatcat tcctgttact ctcacagatt aggtggtact ggagacccag aagccacaac 13320
atccccacta aaaggatact cagtacagtc tatgccaggc attttacagc tgtgacctct 13380
aaggccacct tcagggtagg cttgcctcat tatcctcact aacagatggc agtgcttaag 13440
ggtgggaagg tggagccacc taggtgagac cacccagcta aggaaagaga gctgaggtag 13500
cttacagcat tagctgtcct aagaaacaat ggtggggatt caatatcacc ctccaacaga 13560
agagggcaga agaggcagtg gccatagctt cttagaagat agggcaggcg gagcaggaga 13620
ccaagggcag agcactccag aacacagagg tctctgtccc cagggcttag gaaccaaaga 13680
aggagtcatc attgagatcc tagcttctcg gaccaagaac cagctgagag agataatgaa 13740
ggcatatgag gaaggtaagg ggttgcaaag atggtggggt ggaaacctag acatggccta 13800
cgttttggca acctgatagg gaaaaggagt caggcagttc ccaagggaac tcaaccagag 13860
tggaaaggag cctttggaag gtcttctgag ataaagtcca actagtgccc acgggtgcca 13920
aatcctgtac ccaacagtaa ttgagcatgg ctcagacatg gggagagtga tgtgtgccca 13980
gatgagctca tgtcccttaa tgctgtggca gtgctgggga cgggggcagc agtgggcaag 14040
agtacttgtt ggctgcacat gggttgaccc agaacactag agagggtcat ctgccagggc 14100
cccattatgc taggggagcc ccactggctt actctcctat atagtgccta gccttccagg 14160
caagcaaagg ccagccagtc ctccatgttg tgcttctggc caagggagtc taaaggctct 14220
ggctttgctc aacttggcaa tgaaatagtc tcagtctgca ggctctggtc tggctctctg 14280
gcctgatcta tttctctctc tagcttggtt gcacatttat gtcaacatct gaatgattac 14340
ctagctagat gtctgccaat ttggacatct aaatggggtg tacaccttct gtaccaagaa 14400
cttgtccgcc cgttgggaga agtgtgggaa gcaggtctgg aggaaggaag tggaccctga 14460
caggccctgg gtcactcact gtccattacc tctggttctg tttttctgca gactatggat 14520
ctaccctgga agaagacatc caaggagaca cgagtggcta tctggagcgg attctggtgt 14580
gtctcctgca ggtaacacaa tccagattcc agaactctgt ggcttaaaga tccaaagaga 14640
gccatcccag cacagccctt gagtcatgac tcccagtgag ggctgggcta tggggaaacc 14700
cagcgatctg gaagcaccat ctgtgtgtca gcacaaaagg agggtcctcc ctgagagcct 14760
catgcctctc tttccttatc ctagtgggct ctgctcacta gtgtggctca ctgaatccac 14820
cattccaatg aagtagctca tctactttcg tggtacaaat gccaacagtg aggcatggtg 14880
aggatggctg ctggcttgca ggtctcatgg atcagaagca atagtctttt cctacctgcc 14940
ctctgtaccc cactgtcccc tcagcccagt gttctgagtc ctgacctgcc ttacagagtg 15000
attttctctg atcctagggc agcagagatg atgtgagcgg ctttgtggat ccaggactgg 15060
tcctccaaga tgcacaggta aaacggtacc ttgaccttac cacctgaact ctgagcttta 15120
tgatcccctt tgccaaggag agctttcttt aatatagacc cgtctctgca gcctccacca 15180
tgtgttgact aaggaggaaa gcaggatatc tgggaaactc aatggaagaa aaggaaaaat 15240
ggagaagctg ggaagggagg agctaaggct gtcaggcaga gcgagcctcc ctgagcccag 15300
agcttgctca tgtgcacatc tctgtgtatc tattggtaga gtgcttgtta ctcagtgctc 15360
ccagagacaa tgggggaagg agaattttct aaagaagctg atggcccagg acagaggaga 15420
gccaacacta ttagaggaac aggagttcag gacagtgagc caccatgtta ggctcactga 15480
tggtgagcta gaattctctc tcacctccac ctcctcctgt cccaattcta ggccctgcat 15540
gaagcgggtg agaagattat gggaaccgat gagatgaagt tcatcactat cctgtgcaca 15600
cgcagtgcca ctcacctgat gagaggtaca gggcagaagt gggacacgca ggggtgtgtg 15660
gctgccctag ccacgtggcc tctgcctttg tgtggaaggt ctgatgtgta gtcttaagca 15720
gcttagactt ggggagagag ccatggagac cttgactctt ccccatgtgc caagatggag 15780
gcagaaatgt gctcatactg cactcaggtg cagcgcgtaa tctacgtatc ccttacgtgg 15840
atgcttctct ccatagtg 15858
<210>46
<211>24
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>46
cctaagtaaa cttctgccag cctc 24
<210>47
<211>24
<212>DNA
<213> Artificial sequence (artificacial sequence)
<400>47
cacccagctt tcttgtacaa agtg 24
<210>48
<211>22
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>48
atgggatggg agtttaggtg tg 22
<210>49
<211>23
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>49
aaacagtggg tatgaggatg cag 23
<210>50
<211>25
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>50
gagtgttacc tcagtgactc caggc 25
<210>51
<211>22
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>51
catagggata gagggaggag gt 22
<210>52
<211>22
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>52
gtgggttcat tgacatcact tg 22
<210>53
<211>20
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>53
gtgtgtgatg atgggtcagg 20
<210>54
<211>22
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>54
ccatgtccat agcacatctt gg 22
<210>55
<211>21
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>55
gagggtgact gaggctttaa g 21
<210>56
<211>23
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>56
acacacactt cccaatccat cag 23
<210>57
<211>24
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>57
gtgggtatga ggatgcagtc tagg 24
<210>58
<211>23
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>58
tctccatctg aaggaaccag gtc 23
<210>59
<211>22
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>59
tcttatcatg tctggatccg gg 22
<210>60
<211>23
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>60
tctccatctg aaggaaccag gtc 23
<210>61
<211>23
<212>DNA
<213> Artificial Sequence (Artificial Sequence)
<400>61
atcgtattgg gcagagggtt aag 23

Claims (16)

1. A method for gene targeting by using a CRISPR/Cas9 system is characterized in that based on the CRISPR/Cas9 system, a mutant of Cas9 with DNA single-strand cutting capacity is selected, a tracrRNA/crRNA binary complex or an sgRNA is used for each targeting site, and the mutant of Cas9 recognizes conserved spacer adjacent motifs near the targeting site to generate DNA single-strand cuts without generating DNA double-strand breaks and induce single-strand cut homologous recombination repair.
2. The method of claim 1, wherein said gene targeting comprises gene knock-out, gene knock-in.
3. The method of claim 1, characterized in that the mutant of Cas9 is selected from Cas9n D10A and/or H840A.
4. The method according to claim 1, wherein at least 2 targeting sites are designed for each target gene, and each targeting site is spaced by not less than 100 bp.
5. A method for preparing gene targeting ES cells by using a CRISPR/Cas9 system is characterized by comprising the following steps:
(1) selecting a proper targeting site according to the type of gene targeting and a target gene, and designing a homologous DNA donor and an identification scheme;
(2) preparing a mutant of Cas9 or an expression vector thereof, designing and preparing sgRNA or tracrRNA/crRNA binary complex or respective expression vectors according to a target gene and a targeting site by using the method of any one of claims 1 to 4;
alternatively, a mutant of Cas9, sgRNA, or a co-expression vector of crRNA and tracrRNA is prepared;
(3) transfecting the mutant of Cas9, sgRNA or tracrRNA/crRNA binary complex prepared in the step (1), or respective expression vectors or co-expression vectors into ES cells, selecting and simultaneously transfecting homologous DNA templates according to the type of gene targeting to delete bases of a targeting site or insert exogenous DNA into a genome;
(4) extracting ES cell DNA to perform PCR identification and/or Southern Blot detection and karyotype identification, and identifying the clone which passes the identification to be the gene targeting positive ES cell.
6. The method according to claim 5, wherein the step (2) further comprises detecting the cleavage efficiency of the sgRNA or the binary complex of crRNA and tracrRNA produced.
7. The method of claim 6, wherein the detection comprises endonuclease detection method, SSA reporter vector detection method, Sanger sequencing method, Digenome-Seq technique.
8. Method according to claim 7, characterized in that said endonuclease is selected from the group consisting of SURVEYOR enzymes, T7EN1 enzymes.
9. The method of claim 6, wherein a wild-type Cas9 protein, sgRNA or tracrRNA/crRNA binary complex, or respective expression vectors or co-expression vectors are transfected into ES cells, cell genomes are extracted, target cutting regions are amplified by specific primers, the obtained PCR products are subjected to T7EN1 enzyme digestion, electrophoresis detection is performed after enzyme digestion, the detection result shows that one or more bands are more than those of a control group and the PCR products are regarded as effective cutting, or Sanger sequencing is performed on the obtained PCR products, and the comparison of the sequencing result shows that double peaks appear in the sgRNA regions and the sgRNA regions are regarded as effective cutting; and screening high-efficiency sgRNA or crRNA and tracrRNA.
10. The method according to any one of claims 5 to 9, wherein the method of transfecting ES cells comprises viral transfection, lipofection, or electrotransfection.
11. A method for preparing a gene targeting animal model by using a CRISPR/Cas9 mediated ES targeting technology is characterized in that a gene targeting positive ES cell prepared by the method of any one of claims 5 to 10 is injected into an animal blastocyst, the blastocyst is respectively transplanted into a surrogate mother body for breeding, the produced offspring is an F0 generation chimeric animal, the F1 generation is obtained by breeding with a background wild animal after the F0 generation is sexually mature, and the positive F1 generation animal identified by the gene is the gene targeting animal model.
12. The method of claim 11, wherein the animal model of gene targeting is a mammal.
13. The method of claim 12, wherein the gene targeting animal model is selected from the group consisting of mouse and rat.
14. The method of claim 11, wherein the animal model of gene targeting is a KO, CKO, KI, KOfirst, TM mouse model.
15. The method of claim 14, wherein the animal model of gene targeting is PRKAA1-KI, CD27-KI, ANXA8-CKO animal model.
16. A method for improving screening efficiency of target-hitting ES positive clones based on a CRISPR/Cas9 system is characterized in that a CRISPR/Cas9 system is utilized to select a mutant of Cas9 with DNA single-strand cutting capacity, a tracrRNA/crRNA binary complex or an sgRNA is used for each target hitting site, the mutant of Cas9 recognizes conserved spacer adjacent motifs near the target hitting site, DNA single-strand cuts are generated, double-strand breaks are not generated, and single-strand cut homologous recombination repair is induced.
CN201811535721.7A 2018-12-14 2018-12-14 Method for preparing gene targeting animal model by applying CRISPR/Cas9 mediated ES targeting technology Pending CN111321171A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811535721.7A CN111321171A (en) 2018-12-14 2018-12-14 Method for preparing gene targeting animal model by applying CRISPR/Cas9 mediated ES targeting technology

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811535721.7A CN111321171A (en) 2018-12-14 2018-12-14 Method for preparing gene targeting animal model by applying CRISPR/Cas9 mediated ES targeting technology

Publications (1)

Publication Number Publication Date
CN111321171A true CN111321171A (en) 2020-06-23

Family

ID=71165028

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811535721.7A Pending CN111321171A (en) 2018-12-14 2018-12-14 Method for preparing gene targeting animal model by applying CRISPR/Cas9 mediated ES targeting technology

Country Status (1)

Country Link
CN (1) CN111321171A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113913425A (en) * 2020-12-22 2022-01-11 百迈康生物医药科技(广州)有限公司 sgRNA combination of targeted AHRR gene and application thereof

Citations (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103757053A (en) * 2014-01-28 2014-04-30 中国医学科学院医学生物学研究所 Site-specific modification and screening method for specific DNA (deoxyribonucleic acid) viral genome
CN104726494A (en) * 2015-02-12 2015-06-24 中国人民解放军第二军医大学 Method for constructing chromosome translocation stem cell and animal model by CRISPR-Cas9 technology
CN106061510A (en) * 2013-12-12 2016-10-26 布罗德研究所有限公司 Delivery, use and therapeutic applications of the crispr-cas systems and compositions for genome editing
US20170067078A1 (en) * 2013-12-11 2017-03-09 Regeneron Pharmaceuticals, Inc. Methods and compositions for the targeted modification of a genome
WO2017083368A1 (en) * 2015-11-12 2017-05-18 Pfizer Inc. Tissue-specific genome engineering using crispr-cas9
CN106755097A (en) * 2016-12-27 2017-05-31 安徽省农业科学院畜牧兽医研究所 A kind of goat TLR4 gene knockout carriers and its construction method
CN107130020A (en) * 2017-04-28 2017-09-05 山东大学 Include 163G>FKBP5 genetic fragments, coded protein fragments and its application of C mutation
WO2017160890A1 (en) * 2016-03-14 2017-09-21 Editas Medicine, Inc. Crispr/cas-related methods and compositions for treating beta hemoglobinopathies
CN107208113A (en) * 2014-12-19 2017-09-26 瑞泽恩制药公司 Method and composition for carrying out targeting genetic modification by the multiple targeting of single step
WO2017180694A8 (en) * 2016-04-13 2017-11-16 Editas Medicine, Inc. Cas9 fusion molecules, gene editing systems, and methods of use thereof
CN107429263A (en) * 2015-01-15 2017-12-01 斯坦福大学托管董事会 The method of controlling gene group editor
WO2017216771A2 (en) * 2016-06-17 2017-12-21 Genesis Technologies Limited Crispr-cas system, materials and methods
US20180010134A1 (en) * 2014-09-24 2018-01-11 The Broad Institute Inc. Delivery, use and therapeutic applications of the crispr-cas systems and compositions for modeling competition fo multiple cancer mutations in vivo
WO2018030874A1 (en) * 2016-08-12 2018-02-15 주식회사 툴젠 Manipulated immunoregulatory element and immunity altered thereby
CN107746859A (en) * 2017-10-18 2018-03-02 银丰生物工程集团有限公司 Target the candidate stem cell genetic modification method of Hb H BB mutators
US20180073012A1 (en) * 2016-08-03 2018-03-15 President And Fellows Of Harvard College Adenosine nucleobase editors and uses thereof
US20180119140A1 (en) * 2015-04-06 2018-05-03 The Board Of Trustees Of The Leland Stanford Junior University Chemically Modified Guide RNAs for CRISPR/CAS-Mediated Gene Regulation
WO2018083461A1 (en) * 2016-11-01 2018-05-11 Auxolytic Ltd Regulatable cell lines and methods of use thereof
WO2018119359A1 (en) * 2016-12-23 2018-06-28 President And Fellows Of Harvard College Editing of ccr5 receptor gene to protect against hiv infection
CN108277223A (en) * 2018-01-30 2018-07-13 中国人民解放军南京军区疾病预防控制中心 The structure of sgRNA, SOSSB1 gene delection cell strain for knocking out people's SOSSB1 genes and application
CN108290933A (en) * 2015-06-18 2018-07-17 布罗德研究所有限公司 Reduce the CRISPR enzyme mutants of undershooting-effect
CN108300737A (en) * 2017-12-12 2018-07-20 中国食品药品检定研究院 A kind of method for building up and application thereof for the malignant lymphoma model that phenotype is highly consistent
US20180298392A1 (en) * 2014-11-07 2018-10-18 Editas Medicine, Inc. Methods for improving crispr/cas-mediated genome-editing
CN108949830A (en) * 2018-08-03 2018-12-07 福州大学 A method of realizing genome editor, pinpoint gene knock-in in fish
CN109735498A (en) * 2018-12-14 2019-05-10 江苏集萃药康生物科技有限公司 A kind of construction method of CD137 gene modification humanized animal's model and its application
CN109844118A (en) * 2016-08-12 2019-06-04 株式会社图尔金 Immune-regulating factor through manipulating and the immunity thus changed
CN110951742A (en) * 2019-12-31 2020-04-03 北京市农林科学院 Method for realizing plant gene replacement without generating DNA double-strand break
US20200158716A1 (en) * 2017-07-17 2020-05-21 Massachusetts Institute Of Technology Cell atlas of healthy and diseased barrier tissues
US10851370B1 (en) * 2019-07-08 2020-12-01 Pillargo, Inc. Homologous recombination directed genome editing in eukaryotes

Patent Citations (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170067078A1 (en) * 2013-12-11 2017-03-09 Regeneron Pharmaceuticals, Inc. Methods and compositions for the targeted modification of a genome
CN106061510A (en) * 2013-12-12 2016-10-26 布罗德研究所有限公司 Delivery, use and therapeutic applications of the crispr-cas systems and compositions for genome editing
CN103757053A (en) * 2014-01-28 2014-04-30 中国医学科学院医学生物学研究所 Site-specific modification and screening method for specific DNA (deoxyribonucleic acid) viral genome
US20180010134A1 (en) * 2014-09-24 2018-01-11 The Broad Institute Inc. Delivery, use and therapeutic applications of the crispr-cas systems and compositions for modeling competition fo multiple cancer mutations in vivo
US20180298392A1 (en) * 2014-11-07 2018-10-18 Editas Medicine, Inc. Methods for improving crispr/cas-mediated genome-editing
CN107208113A (en) * 2014-12-19 2017-09-26 瑞泽恩制药公司 Method and composition for carrying out targeting genetic modification by the multiple targeting of single step
CN107429263A (en) * 2015-01-15 2017-12-01 斯坦福大学托管董事会 The method of controlling gene group editor
CN104726494A (en) * 2015-02-12 2015-06-24 中国人民解放军第二军医大学 Method for constructing chromosome translocation stem cell and animal model by CRISPR-Cas9 technology
US20180119140A1 (en) * 2015-04-06 2018-05-03 The Board Of Trustees Of The Leland Stanford Junior University Chemically Modified Guide RNAs for CRISPR/CAS-Mediated Gene Regulation
CN108290933A (en) * 2015-06-18 2018-07-17 布罗德研究所有限公司 Reduce the CRISPR enzyme mutants of undershooting-effect
WO2017083368A1 (en) * 2015-11-12 2017-05-18 Pfizer Inc. Tissue-specific genome engineering using crispr-cas9
WO2017160890A1 (en) * 2016-03-14 2017-09-21 Editas Medicine, Inc. Crispr/cas-related methods and compositions for treating beta hemoglobinopathies
CN109153994A (en) * 2016-03-14 2019-01-04 爱迪塔斯医药公司 For treating β-hemoglobinopathy CRISPR/CAS correlation technique and composition
WO2017180694A8 (en) * 2016-04-13 2017-11-16 Editas Medicine, Inc. Cas9 fusion molecules, gene editing systems, and methods of use thereof
WO2017216771A2 (en) * 2016-06-17 2017-12-21 Genesis Technologies Limited Crispr-cas system, materials and methods
US20190330603A1 (en) * 2016-06-17 2019-10-31 Genesis Technologies Limited Crispr-cas system, materials and methods
US20180073012A1 (en) * 2016-08-03 2018-03-15 President And Fellows Of Harvard College Adenosine nucleobase editors and uses thereof
WO2018030874A1 (en) * 2016-08-12 2018-02-15 주식회사 툴젠 Manipulated immunoregulatory element and immunity altered thereby
CN109844118A (en) * 2016-08-12 2019-06-04 株式会社图尔金 Immune-regulating factor through manipulating and the immunity thus changed
WO2018083461A1 (en) * 2016-11-01 2018-05-11 Auxolytic Ltd Regulatable cell lines and methods of use thereof
CN110121557A (en) * 2016-11-01 2019-08-13 奥克索利提克有限公司 Adjustable cell line and its application method
WO2018119359A1 (en) * 2016-12-23 2018-06-28 President And Fellows Of Harvard College Editing of ccr5 receptor gene to protect against hiv infection
CN106755097A (en) * 2016-12-27 2017-05-31 安徽省农业科学院畜牧兽医研究所 A kind of goat TLR4 gene knockout carriers and its construction method
CN107130020A (en) * 2017-04-28 2017-09-05 山东大学 Include 163G>FKBP5 genetic fragments, coded protein fragments and its application of C mutation
US20200158716A1 (en) * 2017-07-17 2020-05-21 Massachusetts Institute Of Technology Cell atlas of healthy and diseased barrier tissues
CN107746859A (en) * 2017-10-18 2018-03-02 银丰生物工程集团有限公司 Target the candidate stem cell genetic modification method of Hb H BB mutators
CN108300737A (en) * 2017-12-12 2018-07-20 中国食品药品检定研究院 A kind of method for building up and application thereof for the malignant lymphoma model that phenotype is highly consistent
CN108277223A (en) * 2018-01-30 2018-07-13 中国人民解放军南京军区疾病预防控制中心 The structure of sgRNA, SOSSB1 gene delection cell strain for knocking out people's SOSSB1 genes and application
CN108949830A (en) * 2018-08-03 2018-12-07 福州大学 A method of realizing genome editor, pinpoint gene knock-in in fish
CN109735498A (en) * 2018-12-14 2019-05-10 江苏集萃药康生物科技有限公司 A kind of construction method of CD137 gene modification humanized animal's model and its application
US10851370B1 (en) * 2019-07-08 2020-12-01 Pillargo, Inc. Homologous recombination directed genome editing in eukaryotes
CN110951742A (en) * 2019-12-31 2020-04-03 北京市农林科学院 Method for realizing plant gene replacement without generating DNA double-strand break

Non-Patent Citations (15)

* Cited by examiner, † Cited by third party
Title
CHENG, WJ等: "Stearyl polyethylenimine complexed with plasmids as the core of human serum albumin nanoparticles noncovalently bound to CRISPR/Cas9 plasmids or siRNA for disrupting or silencing PD-L1 expression for immunotherapy", 《INTERNATIONAL JOURNAL OF NANOMEDICINE》 *
DEETI K SHETTY等: "Generation of a heterozygous knockout human embryonic stem cell line for the OCIAD1 locus using CRISPR/CAS9 mediated targeting: BJNhem20-OCIAD1-CRISPR-39", 《STEM CELL RES》 *
F ANN RAN等: "Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity", 《CELL》 *
HEITZIG N等: "Mus musculus annexin A8 (Anxa8), transcript variant 2, mRNA", 《NCBI GENBANK》 *
NCBI: "PREDICTED: Mus musculus CD27 antigen (CD27), transcript variant X2, mRNA", 《NCBI GENBANK DATABASE》 *
PRASHANT MALI等: "CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering", 《NAT BIOTECHNOL》 *
TING-WEI WILL CHIANG等: "CRISPR-Cas9(D10A) nickase-based genotypic and phenotypic screening to enhance genome editing", 《SCI REP》 *
WU, XIAOSHENG等: "Targeting B7-H1 (PD-L1) sensitizes cancer cells to chemotherapy", 《HELIYON》 *
YUANPENG GAO等: "Single Cas9 nickase induced generation of NRAMP1 knockin cattle with reduced off-target effects", 《GENOME BIOLOGY》 *
张慧展: "《基因工程 第4版》", 31 January 2017, 华东理工大学出版社 *
徐海春等: "用cre-loxp鼠研究Runx2在釉质发育中的作用", 《中国医疗美容》 *
方佳萍等: "利用CRISPR/Cas9n系统构建Asxl2基因敲除的NIH3T3稳定细胞系", 《天津医药》 *
王少华等: "利用CRISPR/Cas9n技术生产抗蓝耳病的基因编辑克隆猪 ", 《浙江大学学报(农业与生命科学版)》 *
生物探索: "基因敲除常见问题与解答", 《中国实验动物信息网》 *
赵欣等: "CRISPR/Cas基因编辑系统及其在植物中的研究进展 ", 《中国农学通报》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113913425A (en) * 2020-12-22 2022-01-11 百迈康生物医药科技(广州)有限公司 sgRNA combination of targeted AHRR gene and application thereof

Similar Documents

Publication Publication Date Title
AU2016204127B2 (en) Restricted immunoglobulin heavy chain mice
AU2023274083A1 (en) Compositions and methods for treating non-age-associated hearing impairment in a human subject
AU2023204606A1 (en) Genetically modified cells, tissues, and organs for treating disease
DK2150617T3 (en) Regions with increased expression and stability
KR102266274B1 (en) Humanized non-human animals with restricted immunoglobulin heavy chain loci
KR20210143897A (en) Integration of Nucleic Acid Constructs into Eukaryotic Cells Using Transposase from Origias
KR20200126997A (en) Compositions and methods for the treatment of non-aging-related hearing impairment in human subjects
CN111304246B (en) Humanized cytokine animal model, preparation method and application
AU2022200784B2 (en) Non-human animal exhibiting diminished upper and lower motor neuron function and sensory perception
KR20210144861A (en) Translocation of Nucleic Acid Constructs Using Transposase from Amyelois to Eukaryotic Genomes
CN106967723B (en) Gene SCAP related to buffalo lactation and application thereof as molecular marker
CN113088537B (en) Construction method and application of TLR9 gene humanized animal model
KR20220157944A (en) Compositions and methods for treating non-age-related hearing impairment in human subjects
CN111321171A (en) Method for preparing gene targeting animal model by applying CRISPR/Cas9 mediated ES targeting technology
US20020194635A1 (en) Transgenic animals resistant to transmissible spongiform encephalopathies
CN109295000B (en) Application of essential protein CREPT for forming pluripotent stem cells in induction of pluripotent stem cells
RU2817770C2 (en) Integration of nucleic acid constructs into eukaryotic cells with transposase from oryzias
RU2814721C2 (en) Transposition of nucleic acid constructs into eukaryotic genomes with amyelois transposase
CN109295090B (en) Application of cell cycle regulatory protein CREPT in maintaining pluripotency of animal embryonic stem cells
CN108135151A (en) The rodent model of prostate cancer
KR102458464B1 (en) Composition for determining the marbling index of a bovine including an agent capable of detecting or amplifying SNP and kit comprising the same
US20230287460A1 (en) Mammalian cells comprising integrated cas9 genes to produce stable integration sites, and mammalian cells comprising stable integration sites and other sites
RU2797272C1 (en) Genetically modified mice for t-cell receptor
TW202217008A (en) Biomarker for intramuscular fat content traits in pigs

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information
CB02 Change of applicant information

Address after: 210032 building A01, phase III accelerator, Jiangbei new district, Pukou District, Nanjing City, Jiangsu Province

Applicant after: Jiangsu Jicui Yaokang Biotechnology Co., Ltd

Address before: 210032 building A01, phase III accelerator, Jiangbei new district, Pukou District, Nanjing City, Jiangsu Province

Applicant before: GEMPHARMATECH Co.,Ltd.

RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20200623